tamarixetin : A monomethoxyflavone that is quercetin methylated at position O-4'. Isolated from Cyperus teneriffae. [CHeBI]
Assay ID | Title | Year | Journal | Article |
AID1870067 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as inhibition of bacteria-mediated hemolytic activity on rabbit erythrocytes at 128 ug/ml incubated for 30 mins by hemolysis assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1870061 | Inhibition of pvl gene transcription level in methicillin-resistant Staphylococcus aureus USA300 at 64 ug/ml by qPCR analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1188615 | Anticancer activity against human H1299 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1355171 | Inhibition of Escherichia coli DH5alpha infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-6 secretion at 25 uM pretreated for 30 mins followed by Escherichia coli DH5alpha infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355139 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-6 secretion up to 25 uM pretreated for 30 mins followed by LPS-challenge measured after 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID400608 | Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs | 1996 | Journal of natural products, Mar, Volume: 59, Issue:3 ISSN: 0163-3864 | Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes. |
AID1870082 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 infected in C57BL/6J mouse pneumonia model assessed as reduction in IL-6 level in lung at 100 mg/Kg, sc administered every 12 hrs measured after 48 hrs by ELISA | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355138 | Cytotoxicity against C57BL/6 mouse BMDC assessed as effect on cell viability up to 100 uM after 24 hrs by luminescence assay | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1188619 | Anticancer activity against human LOXIMVI cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID353599 | Inhibition of CAMK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay | 2009 | Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7 ISSN: 1520-4804 | Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives. |
AID1355156 | Inhibition of LPS-induced TLR4 activation in C57BL/6 mouse BMDC assessed as reduction in ERK phosphorylation at 25 uM pretreated for 30 mins followed by LPS-challenge measured after 15 to 90 mins by Western blot analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870078 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 infected in C57BL/6J mouse pneumonia model assessed as reduction in bacterial load in lung at 100 mg/Kg, sc administered every 12 hrs measured after 48 hrs in presence of ce | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1188622 | Anticancer activity against human HeLa cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1870056 | Cytotoxicity against human HepG2 cells at 64 ug/ml by MTT assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355186 | Inhibition of Escherichia coli K1 infection-induced immune response in C57BL/6 mouse BMDC assessed as increase in IL10 secretion at 25 uM pretreated for 60 to 120 mins followed by Escherichia coli K1 infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID666771 | Inhibition of thrombin in New Zealand rabbit plasma assessed as fibrinogen level at 100 uM by coagulometry | 2012 | European journal of medicinal chemistry, Aug, Volume: 54ISSN: 1768-3254 | Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors. |
AID1355142 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as increase in IL10 secretion up to 25 uM pretreated for 30 mins followed by LPS-challenge measured after 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID502474 | Inhibition of human CYP1A1 by EROD assay | 2010 | Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17 ISSN: 1464-3391 | Selective inhibition of methoxyflavonoids on human CYP1B1 activity. |
AID1870081 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 infected in C57BL/6J mouse pneumonia model assessed as reduction in IFN-gamma level in lung at 100 mg/Kg, sc administered every 12 hrs measured after 48 hrs by ELISA | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355183 | Inhibition of Escherichia coli K1 infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-6 secretion at 25 uM pretreated for 60 to 120 mins followed by Escherichia coli K1 infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870083 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 infected in C57BL/6J mouse pneumonia model assessed as reduction in TNF-alpha level in lung at 100 mg/Kg, sc administered every 12 hrs measured after 48 hrs by ELISA | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1417124 | Antitrypanosomal activity against Trypanosoma cruzi Tulahuen C2C4 trypomastigotes infected in rat skeletal myoblasts L-6 cells after 96 hrs by CPRG/Nonidet reagent based spectrophotometric method | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157ISSN: 1768-3254 | Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase. |
AID1870051 | Inhibition of methicillin-resistant Staphylococcus aureus USA300 ClpP using Suc-LY-AMC as fluorescent substrate preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1188610 | Anticancer activity against human NCI-H1792 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1154005 | Cytotoxicity against mouse B16F0 cells assessed as cell viability at 6.25 uM after 72 hrs by MTT assay | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13 ISSN: 1464-3391 | Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK. |
AID1264957 | Cytotoxicity against human MSC assessed as cell viability at 5 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 96 to 101%) | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1870093 | Inhibition of methicillin-resistant Staphylococcus aureus USA300 ClpP I84A mutant using Suc-LY-AMC as fluorescent substrate at 64 ug/ml preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355161 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as increase in survival rate at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured over 72 hrs relative to control | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355141 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-12p70 secretion up to 25 uM pretreated for 30 mins followed by LPS-challenge measured after 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1188616 | Anticancer activity against human 292G cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1355153 | Inhibition of LPS-induced TLR4 activation in C57BL/6 mouse BMDC assessed as reduction in Akt phosphorylation at 25 uM pretreated for 30 mins followed by LPS-challenge measured after 15 to 90 mins by Western blot analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355178 | Inhibition of Escherichia coli DH5alpha infection-induced immune response in C57BL/6 mouse BMDC assessed as increase in IL10 secretion at 25 uM pretreated for 60 to 120 mins followed by Escherichia coli DH5alpha infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355150 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as increase in IL10 secretion at 25 uM treated 6 hrs post LPS-challenge measured after 60 to 120 mins by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355169 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as reduction in serum ALT level at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 12 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1634853 | Antitubercular activity against XDR Mycobacterium tuberculosis X59 incubated for 1 to 9 days by inverted microscopic analysis | 2016 | Journal of natural products, Apr-22, Volume: 79, Issue:4 ISSN: 1520-6025 | Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin. |
AID1355165 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as increase in serum IL10 level at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 2 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355147 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-6 secretion at 25 uM treated 6 hrs post LPS-challenge measured after 60 to 120 mins by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355158 | Increase in microRNA187 expression in LPS-induced C57BL/6 mouse BMDC at 25 uM pretreated for 30 mins followed by LPS-challenge measured after 6 hrs by qRT-PCR analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1153997 | Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 6.25 uM after 72 hrs by spectrophotometry relative to control | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13 ISSN: 1464-3391 | Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK. |
AID697853 | Inhibition of horse BChE at 2 mg/ml by Ellman's method | 2012 | Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22 ISSN: 1464-3391 | Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. |
AID1355184 | Inhibition of Escherichia coli K1 infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in TNFalpha secretion at 25 uM pretreated for 60 to 120 mins followed by Escherichia coli K1 infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355193 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in serum ALT level at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 2 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355194 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in serum blood urea nitrogen level at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 2 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1162595 | Inhibition of PMA-stimulated NF-kappaB signaling (unknown origin) expressed in MDA-MB-231 cells at 5 uM incubated for 16 hrs by luciferase reporter gene assay | 2014 | Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19 ISSN: 1464-3405 | Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study. |
AID1355151 | Inhibition of LPS-induced TLR4 activation in C57BL/6 mouse BMDC assessed as reduction in JNK1 phosphorylation at 25 uM pretreated for 30 mins followed by LPS-challenge measured after 15 to 90 mins by Western blot analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870069 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as neutralization of Hla protein in rabbit RBC at 128 ug/ml preincubated for 30 mins followed by RBC addition and measured after 30 mins by hemolysis assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1870094 | Inhibition of methicillin-resistant Staphylococcus aureus USA300 ClpP Q82A mutant using Suc-LY-AMC as fluorescent substrate at 64 ug/ml preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355144 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as reduction in TNFalpha secretion at 25 uM treated 6 hrs post LPS-challenge measured after 30 mins by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870066 | Inhibition of Hla protein expression in methicillin-resistant Staphylococcus aureus Newman at 4 to 64 ug/ml incubated for overnight by western blot analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1634891 | Binding affinity to human ERK1 expressed in Escherichia coli BL21 by fluorescence quenching based spectrofluorometric analysis | 2016 | Journal of natural products, Apr-22, Volume: 79, Issue:4 ISSN: 1520-6025 | Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin. |
AID1162612 | Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method | 2014 | Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19 ISSN: 1464-3405 | Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study. |
AID436267 | Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D6 | 2008 | Journal of natural products, Nov, Volume: 71, Issue:11 ISSN: 1520-6025 | Bioactive diterpenes and other constituents of Croton steenkampianus. |
AID1355149 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-12p70 secretion at 25 uM treated 6 hrs post LPS-challenge measured after 60 to 120 mins by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355155 | Inhibition of LPS-induced TLR4 activation in C57BL/6 mouse BMDC assessed as reduction in IkappaBalpha degradation at 25 uM pretreated for 30 mins followed by LPS-challenge measured after 15 to 90 mins by Western blot analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID666768 | Inhibition of thrombin in New Zealand rabbit plasma assessed as thrombin time at 100 uM after 3 mins by coagulometry | 2012 | European journal of medicinal chemistry, Aug, Volume: 54ISSN: 1768-3254 | Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors. |
AID1870057 | Cytotoxicity against human HEK-293T cells at 64 ug/ml by MTT assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355172 | Inhibition of Escherichia coli DH5alpha infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in TNFalpha secretion at 25 uM pretreated for 30 mins followed by Escherichia coli DH5alpha infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355167 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as reduction in IL6 level in lungs at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 12 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355162 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as reduction in infiltration of immune cells at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 12 hrs by hematoxylin and eosin staining based mic | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1634892 | Binding affinity to human C-terminally His-tagged p38 expressed in Escherichia coli BL21 by fluorescence quenching based spectrofluorometric analysis | 2016 | Journal of natural products, Apr-22, Volume: 79, Issue:4 ISSN: 1520-6025 | Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin. |
AID1355143 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-6 secretion at 25 uM treated 6 hrs post LPS-challenge measured after 30 mins by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870055 | Cytotoxicity against human A549 cells at 64 ug/ml by MTT assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355188 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in serum TNFalpha level at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 2 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870092 | Inhibition of methicillin-resistant Staphylococcus aureus USA300 ClpP K85A mutant using Suc-LY-AMC as fluorescent substrate at 64 ug/ml preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID502473 | Inhibition of human CYP1A2 by EROD assay | 2010 | Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17 ISSN: 1464-3391 | Selective inhibition of methoxyflavonoids on human CYP1B1 activity. |
AID436269 | Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 | 2008 | Journal of natural products, Nov, Volume: 71, Issue:11 ISSN: 1520-6025 | Bioactive diterpenes and other constituents of Croton steenkampianus. |
AID1355196 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as increase in IL10 producing monocyte/macrophage in splenocyte at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 12 hrs by flow cytometric analy | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1264952 | Cytotoxicity against human MSC assessed as cell viability at 10 uM measured on day 1 by alamar blue assay (Rvb = 97 to 101%) | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1355192 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in serum AST level at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 2 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355191 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in infiltration of immune cells in lungs at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 12 hrs by | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID353598 | Inhibition of CK2 assessed as level of ATP utilized by luciferase-based bioluminescence assay | 2009 | Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7 ISSN: 1520-4804 | Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives. |
AID1355187 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as increase in survival rate at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured up to 20 hrs relative to control | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870063 | Inhibition of spa gene transcription level in methicillin-resistant Staphylococcus aureus USA300 at 64 ug/ml by qPCR analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355199 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in bacterial count in lungs at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 12 hrs | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID436271 | Cytotoxicity against african green monkey Vero cells by MTT assay | 2008 | Journal of natural products, Nov, Volume: 71, Issue:11 ISSN: 1520-6025 | Bioactive diterpenes and other constituents of Croton steenkampianus. |
AID1870052 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as bacterial growth inhibition at 64 ug/ml incubated for 24 hrs by growth curve assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1264945 | Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 1 uM using p-NPP as substrate after 9 days by colorimetric method relative to control | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1355197 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as increase in IL10 producing Tr1 population in splenocyte at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 12 hrs by flow cytometric analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID502475 | Inhibition of human CYP1B1 by EROD assay | 2010 | Bioorganic & medicinal chemistry, Sep-01, Volume: 18, Issue:17 ISSN: 1464-3391 | Selective inhibition of methoxyflavonoids on human CYP1B1 activity. |
AID1355179 | Inhibition of Escherichia coli K1 infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-6 secretion at 25 uM pretreated for 30 mins followed by Escherichia coli K1 infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355201 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in bacterial count in kidneys at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 12 hrs | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID288326 | Inhibition of 5-LO activity in ionophore A23187 and arachidonic-stimulated human intact PMNL | 2007 | Journal of medicinal chemistry, May-31, Volume: 50, Issue:11 ISSN: 0022-2623 | Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. |
AID1355170 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as reduction in serum blood urea nitrogen level at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 12 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870070 | Inhibition of PVL protein expression in methicillin-resistant Staphylococcus aureus USA300 incubated for overnight by western blot analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1264954 | Cytotoxicity against human MSC assessed as cell viability at 5 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 97 to 100%) | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1417091 | Inhibition of human DHODH at 100 uM | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157ISSN: 1768-3254 | Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase. |
AID1634852 | Antitubercular activity against XDR Mycobacterium tuberculosis X24 incubated for 1 to 9 days by inverted microscopic analysis | 2016 | Journal of natural products, Apr-22, Volume: 79, Issue:4 ISSN: 1520-6025 | Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin. |
AID353591 | Enhancement of HSP27 Ser78 phosphorylation in human HeLa cells at 50 ug/mL treated for 1 hr | 2009 | Journal of medicinal chemistry, Apr-09, Volume: 52, Issue:7 ISSN: 1520-4804 | Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives. |
AID1870086 | Synergistic antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 infected in C57BL/6J mouse pneumonia model assessed as reduction in infiltration of inflammatory cells in alveoli at 100 mg/Kg, sc administered every 12 hrs meas | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1188618 | Anticancer activity against human M4E cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1417093 | Inhibition of recombinant oligo-histidine-tagged Leishmania major DHODH expressed in Escherichia coli BL21(DE3) cells at 100 uM using DHO as substrate measured after 60 secs | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157ISSN: 1768-3254 | Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase. |
AID616482 | Antioxidant activity assessed as DPPH free radical scavenging activity | 2011 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 21, Issue:18 ISSN: 1464-3405 | Synthesis and antioxygenic activities of seabuckthorn flavone-3-ols and analogs. |
AID1870084 | Synergistic antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 infected in C57BL/6J mouse pneumonia model assessed as lethality at 50 mg/Kg, sc administered every 12 hrs measured after 72 hrs in presence of cefotaxime (Rvb = | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID605939 | Antiestrogenic activity in human MCF7/BUS cells assessed as inhibition of 17beta-estradiol-induced cell proliferation at 10 uM after 6 days by E-Screen test | 2011 | Journal of natural products, May-27, Volume: 74, Issue:5 ISSN: 1520-6025 | Benzodihydrofurans from Cyperus teneriffae. |
AID1355145 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-12p70 secretion at 25 uM treated 6 hrs post LPS-challenge measured after 30 mins by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1264950 | Cytotoxicity against human MSC assessed as cell viability at 1 uM measured on day 1 by alamar blue assay (Rvb = 97 to 101%) | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1355163 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as reduction in serum TNFalpha level at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 2 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355152 | Inhibition of LPS-induced TLR4 activation in C57BL/6 mouse BMDC assessed as reduction in p38 phosphorylation at 25 uM pretreated for 30 mins followed by LPS-challenge measured after 15 to 90 mins by Western blot analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870076 | Binding affinity to methicillin-resistant Staphylococcus aureus USA300 ClpP assessed as dissociation constant by surface plasmon resonance assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1188611 | Anticancer activity against human NCI-H1944 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1154004 | Cytotoxicity against mouse B16F0 cells assessed as cell viability at 12.5 uM after 72 hrs by MTT assay | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13 ISSN: 1464-3391 | Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK. |
AID1355154 | Inhibition of LPS-induced TLR4 activation in C57BL/6 mouse BMDC assessed as reduction in COX2 expression at 25 uM pretreated for 30 mins followed by LPS-challenge measured after 15 to 90 mins by Western blot analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1188609 | Anticancer activity against human H460 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID697852 | Inhibition of electric eel AChE at 2 mg/ml by Ellman's method | 2012 | Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22 ISSN: 1464-3391 | Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. |
AID1870080 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 harboring delta ClpP mutant infected in C57BL/6J mouse pneumonia model assessed as reduction in infiltration of inflammatory cells in alveoli at 100 mg/Kg, sc administered e | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1870074 | Binding affinity to methicillin-resistant Staphylococcus aureus USA300 ClpP assessed as association rate constant by surface plasmon resonance assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355189 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in serum IL6 level at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 2 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870088 | Synergistic antifungal activity against Cmethicillin-resistant Staphylococcus aureus USA300 assessed as fractional inhibitory concentration index at 64 ug/ml in presence of cefotaxime by checker board method | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1264953 | Cytotoxicity against human MSC assessed as cell viability at 1 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 97 to 100%) | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1188620 | Anticancer activity against human M14 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1634850 | Antitubercular activity against MDR Mycobacterium tuberculosis M22 incubated for 1 to 9 days by inverted microscopic analysis | 2016 | Journal of natural products, Apr-22, Volume: 79, Issue:4 ISSN: 1520-6025 | Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin. |
AID1355204 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as increase in survival rate at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured over 72 hrs relative to control | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1188607 | Anticancer activity against human A549 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1870085 | Synergistic antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 infected in C57BL/6J mouse pneumonia model assessed as reduction in bacterial load in lung at 100 mg/Kg, sc administered every 12 hrs measured after 48 hrs in pr | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1870050 | Inhibition of methicillin-resistant Staphylococcus aureus USA300 ClpP using Suc-LY-AMC as fluorescent substrate at 64 ug/ml preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay relative to control | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1188621 | Anticancer activity against human SKBR cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID666769 | Inhibition of thrombin in New Zealand rabbit plasma assessed as prothrombin time at 100 uM by coagulometry | 2012 | European journal of medicinal chemistry, Aug, Volume: 54ISSN: 1768-3254 | Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors. |
AID436270 | Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D10 | 2008 | Journal of natural products, Nov, Volume: 71, Issue:11 ISSN: 1520-6025 | Bioactive diterpenes and other constituents of Croton steenkampianus. |
AID1870072 | Binding affinity to methicillin-resistant Staphylococcus aureus USA300 ClpP assessed as decrease in thermal stability of the protein at 16 to 64 ug/ml by SYPRO orange thermal shift assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1154000 | Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 12.5 uM after 72 hrs by spectrophotometry relative to control | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13 ISSN: 1464-3391 | Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK. |
AID1355181 | Inhibition of Escherichia coli K1 infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-12p70 secretion at 25 uM pretreated for 30 mins followed by Escherichia coli K1 infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870053 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 harboring ClpP delta mutant assessed as bacterial growth inhibition at 64 ug/ml incubated for 24 hrs by growth curve assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1153996 | Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 12.5 uM after 72 hrs by spectrophotometry relative to control | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13 ISSN: 1464-3391 | Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK. |
AID1153999 | Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 25 uM after 72 hrs by spectrophotometry relative to control | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13 ISSN: 1464-3391 | Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK. |
AID1870060 | Inhibition of RNAIII gene transcription level in methicillin-resistant Staphylococcus aureus USA300 at 64 ug/ml by qPCR analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1870090 | Inhibition of methicillin-resistant Staphylococcus aureus USA300 ClpP K109A mutant using Suc-LY-AMC as fluorescent substrate at 64 ug/ml preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID436268 | Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 | 2008 | Journal of natural products, Nov, Volume: 71, Issue:11 ISSN: 1520-6025 | Bioactive diterpenes and other constituents of Croton steenkampianus. |
AID1355177 | Inhibition of Escherichia coli DH5alpha infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-12p70 secretion at 25 uM pretreated for 60 to 120 mins followed by Escherichia coli DH5alpha infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1264948 | Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity using p-NPP as substrate after 9 days by colorimetric method | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1188617 | Anticancer activity against human Calu1 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1355176 | Inhibition of Escherichia coli DH5alpha infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in TNFalpha secretion at 25 uM pretreated for 60 to 120 mins followed by Escherichia coli DH5alpha infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1334868 | Inhibition of LPS-stimulated nitric oxide production in ddy mouse peritoneal macrophages measured after 20 hrs by Greiss method | 2017 | Bioorganic & medicinal chemistry, 01-15, Volume: 25, Issue:2 ISSN: 1464-3391 | Structure-activity relationship of the inhibitory effects of flavonoids on nitric oxide production in RAW264.7 cells. |
AID1355146 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as increase in IL10 secretion at 25 uM treated 6 hrs post LPS-challenge measured after 30 mins by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870075 | Binding affinity to methicillin-resistant Staphylococcus aureus USA300 ClpP assessed as dissociation rate constant by surface plasmon resonance assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1264958 | Cytotoxicity against human MSC assessed as cell viability at 10 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 96 to 101%) | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1355148 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as reduction in TNFalpha secretion at 25 uM treated 6 hrs post LPS-challenge measured after 60 to 120 mins by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1417094 | Inhibition of recombinant oligo-histidine-tagged Leishmania major DHODH expressed in Escherichia coli BL21(DE3) cells using DHO as substrate measured after 60 secs | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157ISSN: 1768-3254 | Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase. |
AID1355195 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as increase in IL10 producing dendritic cells in splenocyte at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 12 hrs by flow cytometric analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1264947 | Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 10 uM using p-NPP as substrate after 9 days by colorimetric method relative to control | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1870062 | Inhibition of PSM-alpha gene transcription level in methicillin-resistant Staphylococcus aureus USA300 at 64 ug/ml by qPCR analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355157 | Binding affinity to human C-terminal His6-tagged JNK1alpha1 (1 to 364 residues) expressed in Escherichia coli by tryptophan fluorescence quenching assay | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870079 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 infected in C57BL/6J mouse pneumonia model assessed as reduction in infiltration of inflammatory cells in alveoli at 100 mg/Kg, sc administered every 12 hrs measured after 4 | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1870058 | Inhibition of hla gene transcription level in methicillin-resistant Staphylococcus aureus USA300 at 64 ug/ml by qPCR analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355166 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as reduction in TNFalpha level in lungs at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 12 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355200 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in bacterial count in liver at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 12 hrs | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355173 | Inhibition of Escherichia coli DH5alpha infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-12p70 secretion at 25 uM pretreated for 30 mins followed by Escherichia coli DH5alpha infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1153995 | Intracellular melanogenesis-stimulating activity in mouse B16F0 cells at 25 uM after 72 hrs by spectrophotometry relative to control | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13 ISSN: 1464-3391 | Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK. |
AID1870054 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 incubated for 24 hrs by microdilution broth assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1870077 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 harboring delta ClpP mutant infected in C57BL/6J mouse pneumonia model assessed as reduction in mortality rate at 50 mg/Kg, sc administered every 12 hrs measured after 72 hr | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355159 | Increase in microRNA146a expression in LPS-induced C57BL/6 mouse BMDC at 25 uM pretreated for 30 mins followed by LPS-challenge measured after 6 hrs by qRT-PCR analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1634849 | Antitubercular activity against Mycobacterium tuberculosis H37Rv P887 incubated for 1 to 9 days by inverted microscopic analysis | 2016 | Journal of natural products, Apr-22, Volume: 79, Issue:4 ISSN: 1520-6025 | Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin. |
AID1355140 | Inhibition of LPS-induced immune response in C57BL/6 mouse BMDC assessed as reduction in TNFalpha secretion up to 25 uM pretreated for 30 mins followed by LPS-challenge measured after 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1634855 | Lipophilicity, logP of the compound | 2016 | Journal of natural products, Apr-22, Volume: 79, Issue:4 ISSN: 1520-6025 | Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin. |
AID1355185 | Inhibition of Escherichia coli K1 infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-12p70 secretion at 25 uM pretreated for 60 to 120 mins followed by Escherichia coli K1 infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355164 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as reduction in serum IL6 level at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 2 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1634851 | Antitubercular activity against MDR Mycobacterium tuberculosis X23 incubated for 1 to 9 days by inverted microscopic analysis | 2016 | Journal of natural products, Apr-22, Volume: 79, Issue:4 ISSN: 1520-6025 | Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin. |
AID1154001 | Extracellular melanogenesis-stimulating activity in mouse B16F0 cells at 6.25 uM after 72 hrs by spectrophotometry relative to control | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13 ISSN: 1464-3391 | Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK. |
AID666770 | Inhibition of thrombin in New Zealand rabbit plasma assessed as activated partial thromboplastin time at 100 uM after 3 mins by coagulometry | 2012 | European journal of medicinal chemistry, Aug, Volume: 54ISSN: 1768-3254 | Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors. |
AID1188612 | Anticancer activity against human H266 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1188608 | Anticancer activity against human NCI-H157 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1870087 | Synergistic antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as cefotaxime MIC by checker board method | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355190 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as increase in serum IL10 level at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 2 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870095 | Inhibition of methicillin-resistant Staphylococcus aureus USA300 ClpP assessed as upregulation of urease production at 64 ug/ml incubated for 4 hr by spectrophotometry | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1417130 | Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 trypomastigotes after 72 hrs by Alamar Blue assay | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157ISSN: 1768-3254 | Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase. |
AID1264946 | Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 5 uM using p-NPP as substrate after 9 days by colorimetric method relative to control | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1162613 | Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method | 2014 | Bioorganic & medicinal chemistry letters, Oct-01, Volume: 24, Issue:19 ISSN: 1464-3405 | Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells--A SAR study. |
AID1264949 | Cytotoxicity against human MSC assessed as decrease in cell number at 1 to 10 uM after 9 days by methylene blue staining based microscopy relative to control | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1355160 | Increase in microRNA155 expression in LPS-induced C57BL/6 mouse BMDC at 25 uM pretreated for 30 mins followed by LPS-challenge measured after 6 hrs by qRT-PCR analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870073 | Binding affinity to methicillin-resistant Staphylococcus aureus USA300 ClpP assessed as change in thermal stability by measuring protein deposition at 64 ug/ml by measured after 1 hr by cellular thermal shift assay (Rvb = 65 degC) | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1870064 | Inhibition of agrA gene transcription level in methicillin-resistant Staphylococcus aureus USA300 at 64 ug/ml by qPCR analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355198 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as increase in IL10 producing B10 population in splenocyte at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 12 hrs by flow cytometric analysis | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870059 | Inhibition of agr gene transcription level in methicillin-resistant Staphylococcus aureus USA300 at 64 ug/ml by qPCR analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355202 | Antiseptic activity in Balb/c mouse model of Escherichia coli K1 infection-induced sepsis assessed as reduction in serum endotoxin level at 1 mg/kg, ip pretreated for 1 hr followed by Escherichia coli K1 infection measured after 12 hrs by chromogenic assa | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1417122 | Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes after 72 hrs by Alamar Blue assay | 2018 | European journal of medicinal chemistry, Sep-05, Volume: 157ISSN: 1768-3254 | Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase. |
AID1188614 | Anticancer activity against human HOP62 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1323133 | Antioxidant activity assessed as DPPH free radical scavenging activity at 5 uM after 15 to 60 mins in presence of CuSO4.5H2O | 2016 | Journal of natural products, 07-22, Volume: 79, Issue:7 ISSN: 1520-6025 | Effects of Functional Groups and Sugar Composition of Quercetin Derivatives on Their Radical Scavenging Properties. |
AID1264951 | Cytotoxicity against human MSC assessed as cell viability at 5 uM measured on day 1 by alamar blue assay (Rvb = 97 to 101%) | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1870091 | Inhibition of methicillin-resistant Staphylococcus aureus USA300 ClpP A106G mutant using Suc-LY-AMC as fluorescent substrate at 64 ug/ml preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355175 | Inhibition of Escherichia coli DH5alpha infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in IL-6 secretion at 25 uM pretreated for 60 to 120 mins followed by Escherichia coli DH5alpha infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870065 | Inhibition of Hla protein expression in methicillin-resistant Staphylococcus aureus USA300 at 4 to 64 ug/ml incubated for overnight by western blot analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1870089 | Inhibition of methicillin-resistant Staphylococcus aureus USA300 ClpP R157A mutant using Suc-LY-AMC as fluorescent substrate at 64 ug/ml preincubated for 1 hr followed by substrate addition and measured after 1 hr by FRET assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1870068 | Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 harboring ClpP delta mutant assessed as inhibition of bacteria-mediated hemolytic activity on rabbit erythrocytes at 128 ug/ml incubated for 30 mins by hemolysis assay | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355180 | Inhibition of Escherichia coli K1 infection-induced immune response in C57BL/6 mouse BMDC assessed as reduction in TNFalpha secretion at 25 uM pretreated for 30 mins followed by Escherichia coli K1 infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1264955 | Cytotoxicity against human MSC assessed as cell viability at 10 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 97 to 100%) | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1355168 | Antiinflammatory activity in Balb/c mouse model of LPS-induced endotoxemia assessed as reduction in serum AST level at 1 mg/kg, ip pretreated for 1 hr followed by LPS-challenge measured after 12 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1870071 | Inhibition of PVL protein expression in methicillin-resistant Staphylococcus aureus Newman incubated for overnight by western blot analysis | 2022 | Journal of natural products, 08-26, Volume: 85, Issue:8 ISSN: 1520-6025 | Tamarixetin Attenuated the Virulence of |
AID1355182 | Inhibition of Escherichia coli K1 infection-induced immune response in C57BL/6 mouse BMDC assessed as increase in IL10 secretion at 25 uM pretreated for 30 mins followed by Escherichia coli K1 infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1355174 | Inhibition of Escherichia coli DH5alpha infection-induced immune response in C57BL/6 mouse BMDC assessed as increase in IL10 secretion at 25 uM pretreated for 30 mins followed by Escherichia coli DH5alpha infection for 6 hrs by ELISA | 2018 | Journal of natural products, 06-22, Volume: 81, Issue:6 ISSN: 1520-6025 | Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production. |
AID1264956 | Cytotoxicity against human MSC assessed as cell viability at 1 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 96 to 101%) | 2015 | Journal of natural products, Nov-25, Volume: 78, Issue:11 ISSN: 1520-6025 | Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids. |
AID1188613 | Anticancer activity against human NCI-H522 cells by HTS assay | 2014 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18 ISSN: 1464-3405 | Synthesis, biological evaluation and SAR analysis of O-alkylated analogs of quercetin for anticancer. |
AID1154003 | Cytotoxicity against mouse B16F0 cells assessed as cell viability at 25 uM after 72 hrs by MTT assay | 2014 | Bioorganic & medicinal chemistry, Jul-01, Volume: 22, Issue:13 ISSN: 1464-3391 | Synthesized quercetin derivatives stimulate melanogenesis in B16 melanoma cells by influencing the expression of melanin biosynthesis proteins MITF and p38 MAPK. |
AID1801097 | Aurora B Kinase Assay from Article 10.1111/cbdd.12445: \\Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.\\ | 2015 | Chemical biology & drug design, May, Volume: 85, Issue:5 ISSN: 1747-0285 | Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships. |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
alpha-hydroxyglutarate | | 2-hydroxydicarboxylic acid; dicarboxylic fatty acid | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-isopropylmalate | | 2-hydroxy carboxylic acid; 3-hydroxy carboxylic acid; dicarboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetoacetic acid | | 3-oxo fatty acid; ketone body | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxybenzyl alcohol | | hydroxybenzyl alcohol; phenols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-carbamoyl-beta-alanine | | beta-alanine derivative | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethylene glycol | | ethanediol; glycol | metabolite; mouse metabolite; solvent; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetoin | | methyl ketone; secondary alpha-hydroxy ketone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ammonium hydroxide | | azane; gas molecular entity; mononuclear parent hydride | EC 3.5.1.4 (amidase) inhibitor; metabolite; mouse metabolite; neurotoxin; NMR chemical shift reference compound; nucleophilic reagent; refrigerant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzyl alcohol | | benzyl alcohols | antioxidant; fragrance; metabolite; solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carbon monoxide | | carbon oxide; gas molecular entity; one-carbon compound | biomarker; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; human metabolite; ligand; metabolite; mitochondrial respiratory-chain inhibitor; mouse metabolite; neurotoxin; neurotransmitter; P450 inhibitor; probe; signalling molecule; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
formic acid | | monocarboxylic acid | antibacterial agent; astringent; metabolite; protic solvent; solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxymandelic acid | | 2-hydroxy carboxylic acid; phenols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aminoethylphosphonic acid | | phosphonic acids; primary amino compound; zwitterion | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydrogen sulfide | | gas molecular entity; hydracid; mononuclear parent hydride; sulfur hydride | Escherichia coli metabolite; genotoxin; metabolite; signalling molecule; toxin; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-aminophenol | | aminophenol | allergen; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(1)-acetylspermidine | | acetylspermidine | Escherichia coli metabolite; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aminocaproic acid | | amino acid zwitterion; epsilon-amino acid; omega-amino fatty acid | antifibrinolytic drug; hematologic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydrouracil | | pyrimidone | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroxyacetone | | ketotriose; primary alpha-hydroxy ketone | antifungal agent; Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dimethylamine | | methylamines; secondary aliphatic amine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycolic acid | | 2-hydroxy monocarboxylic acid; primary alcohol | keratolytic drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydantoin-5-propionic acid | | imidazolidine-2,4-dione; monocarboxylic acid | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
niacinamide | | pyridine alkaloid; pyridinecarboxamide; vitamin B3 | anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
niacin | | pyridine alkaloid; pyridinemonocarboxylic acid; vitamin B3 | antidote; antilipemic drug; EC 3.5.1.19 (nicotinamidase) inhibitor; Escherichia coli metabolite; human urinary metabolite; metabolite; mouse metabolite; plant metabolite; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
orotic acid | | pyrimidinemonocarboxylic acid | Escherichia coli metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxaloacetic acid | | C4-dicarboxylic acid; oxo dicarboxylic acid | geroprotector; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
porphobilinogen | | aralkylamino compound; dicarboxylic acid; pyrroles | Escherichia coli metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-propanol | | propan-1-ols; short-chain primary fatty alcohol | metabolite; protic solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trimethyloxamine | | tertiary amine oxide | Escherichia coli metabolite; metabolite; osmolyte | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-hydroxymelatonin | | acetamides; tryptamines | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylphenylalanine | | N-acetyl-amino acid; phenylalanine derivative | antidepressant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetyltryptophan | | N-acetyl-amino acid; tryptophan derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arecoline | | enoate ester; methyl ester; pyridine alkaloid; tetrahydropyridine | metabolite; muscarinic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid i | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
berberine | | alkaloid antibiotic; berberine alkaloid; botanical anti-fungal agent; organic heteropentacyclic compound | antilipemic drug; antineoplastic agent; antioxidant; EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor; EC 1.21.3.3 (reticuline oxidase) inhibitor; EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.11.10 (IkappaB kinase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; hypoglycemic agent; metabolite; potassium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dibutyl phthalate | | diester; phthalate ester | EC 3.2.1.20 (alpha-glucosidase) inhibitor; environmental contaminant; metabolite; plasticiser; teratogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxymethyltolbutamide | | benzyl alcohols; sulfonamide; ureas | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl salicylate | | benzoate ester; methyl ester; salicylates | flavouring agent; insect attractant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
myristicin | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenmetrazine | | morpholines | metabolite; sympathomimetic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylbutazone | | pyrazolidines | antirheumatic drug; EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor; metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
safrole | | benzodioxoles | flavouring agent; insecticide; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,2'-thiodiethanol | | aliphatic sulfide; diol | antineoplastic agent; antioxidant; metabolite; solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sorbitol | | glucitol | cathartic; Escherichia coli metabolite; food humectant; human metabolite; laxative; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite; sweetening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alloxan | | pyrimidone | hyperglycemic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thymidine | | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glutamine | | amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
allyl isothiocyanate | | alkenyl isothiocyanate; isothiocyanate | antimicrobial agent; antineoplastic agent; apoptosis inducer; lachrymator; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methyltryptamine | | tryptamine alkaloid; tryptamines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-deoxypyridoxine | | hydroxymethylpyridine; methylpyridines; monohydroxypyridine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cycloserine | | 4-amino-1,2-oxazolidin-3-one; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic; zwitterion | antiinfective agent; antimetabolite; antitubercular agent; metabolite; NMDA receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
17-alpha-hydroxyprogesterone | | 17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; tertiary alpha-hydroxy ketone | human metabolite; metabolite; mouse metabolite; progestin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mannitol | | mannitol | allergen; antiglaucoma drug; compatible osmolytes; Escherichia coli metabolite; food anticaking agent; food bulking agent; food humectant; food stabiliser; food thickening agent; hapten; metabolite; osmotic diuretic; sweetening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenacyl bromide | | acetophenones; alpha-bromoketone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trichloroacetic acid | | monocarboxylic acid; organochlorine compound | carcinogenic agent; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acrylic acid | | alpha,beta-unsaturated monocarboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methylacetamide | | acetamides; monocarboxylic acid amide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bis(4-hydroxyphenyl)sulfone | | bisphenol; sulfone | endocrine disruptor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rotenone | | organic heteropentacyclic compound; rotenones | antineoplastic agent; metabolite; mitochondrial NADH:ubiquinone reductase inhibitor; phytogenic insecticide; piscicide; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-amino-4-hydroxy-2-naphthalenesulfonic acid | | aminonaphthalenesulfonic acid; naphthols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl benzoate | | benzoate ester; methyl ester | insect attractant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-dichlorobenzene | | dichlorobenzene | hepatotoxic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-diaminotoluene | | aminotoluene | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-butyrolactone | | butan-4-olide | metabolite; neurotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulfosalicylic acid | | arenesulfonic acid; benzoic acids; phenols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl lactate | | ethyl ester; lactate ester; secondary alcohol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
furaldehyde | | aldehyde; furans | Maillard reaction product; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiophene-2-carboxaldehyde | | aldehyde; thiophenes | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-resorcylic acid | | dihydroxybenzoic acid; resorcinols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylenebis(chloroaniline) | | chloroaniline | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-phenylethyl acetate | | acetate ester | metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dibenzyl ether | | benzyl ether | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl propionate | | propanoate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
citronellal | | aldehyde; monoterpenoid | antifungal agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl oenanthate | | fatty acid ethyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl caprylate | | fatty acid ethyl ester; octanoate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl laurate | | fatty acid ethyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetic anhydride | | acyclic carboxylic anhydride | metabolite; reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl isovalerate | | fatty acid ethyl ester; olefinic compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-butyl n-butyrate | | butyrate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl decanoate | | decanoate ester; fatty acid ethyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl octanoate | | fatty acid methyl ester; octanoate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-octanone | | methyl ketone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexylamine | | primary aliphatic amine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lauric acid methyl ester | | dodecanoate ester; fatty acid methyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
octylamine | | primary aliphatic amine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-decyl alcohol | | decanol; primary alcohol | metabolite; pheromone; protic solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl palmitate | | fatty acid methyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
maltol | | 4-pyranones | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloranil | | 1,4-benzoquinones; organochlorine compound | EC 2.7.1.33 (pantothenate kinase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dibenzoylmethane | | aromatic ketone; beta-diketone | antimutagen; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl anthranilate | | benzoate ester | flavouring agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzyl acetate | | acetate ester; benzyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl acetate | | acetate ester; ethyl ester; volatile organic compound | EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor; metabolite; polar aprotic solvent; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dibenzyl disulfide | | organic aromatic compound; organic disulfide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mequinol | | methoxybenzenes; phenols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-resorcylic acid | | dihydroxybenzoic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kynuramine | | kynurenamines; primary amino compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methylpyrazole-3-carboxylic acid | | monocarboxylic acid; pyrazoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-trifluoromethylaniline | | (trifluoromethyl)benzenes; substituted aniline | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylguanidine | | guanidines | EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite; uremic toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
liriodenine | | alkaloid antibiotic; cyclic ketone; organic heteropentacyclic compound; oxacycle; oxoaporphine alkaloid | antifungal agent; antimicrobial agent; antineoplastic agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
plumbagin | | hydroxy-1,4-naphthoquinone; phenols | anticoagulant; antineoplastic agent; immunological adjuvant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
imperatorin | | psoralens | EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
osthol | | botanical anti-fungal agent; coumarins | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Dillapiole | | benzodioxoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
coumaran | | 1-benzofurans | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-propanediol | | propane-1,3-diols | metabolite; protic solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tridecanedioic acid | | alpha,omega-dicarboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
physcione | | dihydroxyanthraquinone | anti-inflammatory agent; antibacterial agent; antifungal agent; antineoplastic agent; apoptosis inducer; hepatoprotective agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
apiole | | benzodioxoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flavone | | flavones | metabolite; nematicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cetyl palmitate | | hexadecanoate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-amyl butyrate | | butyrate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-aminobutyric acid | | amino acid zwitterion; beta-amino acid; monocarboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl lactate | | lactate ester; methyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
paeonol | | methoxybenzenes; phenols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,2-dimethylbutyric acid | | dimethylbutyric acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-chloroacrylic acid | | alpha,beta-unsaturated monocarboxylic acid; chlorocarboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
galactitol | | hexitol | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-methyluracil | | nucleobase analogue; pyrimidone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-pyrrolidone | | pyrrolidin-2-ones | metabolite; polar solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-ethylacetamide | | acetamides | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-methyluracil | | pyrimidone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylglutaric acid | | alpha,omega-dicarboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amyl acetate | | acetate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dibenzothiophene 5-oxide | | dibenzothiophenes | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-acetamidoethanethiol | | acetamides | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxyquinoxaline | | hydroxyquinoxaline | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxyacetophenone | | acetophenones; catechols; dihydroxyacetophenone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl hippurate | | glycine derivative; methyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isobarbaloin | | anthracenes; C-glycosyl compound; cyclic ketone; phenols | laxative; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vincamine | | alkaloid ester; hemiaminal; methyl ester; organic heteropentacyclic compound; vinca alkaloid | antihypertensive agent; metabolite; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl tert-butyl ether | | ether | fuel additive; metabolite; non-polar solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-octylphenol | | phenols | metabolite; surfactant; xenoestrogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dronabinol | | benzochromene; diterpenoid; phytocannabinoid; polyketide | cannabinoid receptor agonist; epitope; hallucinogen; metabolite; non-narcotic analgesic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenethyl isothiocyanate | | isothiocyanate | antineoplastic agent; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-1,4-naphthoquinone | | 1,4-naphthoquinones; enol ether | antimicrobial agent; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aviprin | | furanocoumarin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxyphenytoin | | imidazolidine-2,4-dione; phenols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
squaric acid | | alicyclic ketone; carbon oxoacid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl methanethiosulfonate | | sulfonic acid derivative; thiosulfonate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arabinofuranosyluracil | | N-glycosyl compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-aminonicotinic acid | | aminonicotinic acid; aminopyridine; aromatic amine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mannose | | D-aldohexose; D-mannose; mannopyranose | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,3-hexanedione | | alpha-diketone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tabersonine | | alkaloid ester; methyl ester; monoterpenoid indole alkaloid; organic heteropentacyclic compound | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,3-dimethylglutarate | | alpha,omega-dicarboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
raspberry ketone | | methyl ketone; phenols | androgen antagonist; cosmetic; flavouring agent; fragrance; hepatoprotective agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
laurolitsine | | aporphine alkaloid; aromatic ether; phenols | HIV-1 integrase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
helenalin | | cyclic ketone; gamma-lactone; organic heterotricyclic compound; secondary alcohol; sesquiterpene lactone | anti-inflammatory agent; antineoplastic agent; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diethyl malate | | malate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carbendazim | | benzimidazole fungicide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | antifungal agrochemical; antinematodal drug; metabolite; microtubule-destabilising agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glucoheptonate | | carbohydrate acid; monocarboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deslanoside | | 12beta-hydroxy steroid; 14beta-hydroxy steroid; cardenolide glycoside; tetrasaccharide derivative | anti-arrhythmia drug; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
streptozocin | | N-acylglucosamine; N-nitrosoureas | antimicrobial agent; antineoplastic agent; DNA synthesis inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pedalitin | | monomethoxyflavone; tetrahydroxyflavone | EC 1.17.3.2 (xanthine oxidase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl nonanoate | | fatty acid ethyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl hexanoate | | fatty acid ethyl ester; hexanoate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butyl acetate | | acetate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,4-dioxane | | dioxane; volatile organic compound | carcinogenic agent; metabolite; NMR chemical shift reference compound; non-polar solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoamyl acetate | | acetate ester | metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ribostamycin | | amino cyclitol glycoside; aminoglycoside antibiotic | antibacterial drug; antimicrobial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tramadol | | 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol | adrenergic uptake inhibitor; antitussive; capsaicin receptor antagonist; delta-opioid receptor agonist; kappa-opioid receptor agonist; metabolite; mu-opioid receptor agonist; muscarinic antagonist; nicotinic antagonist; NMDA receptor antagonist; opioid analgesic; serotonergic antagonist; serotonin uptake inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-pentylpyrone | | 2-pyranones | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
paclitaxel | | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methylhistamine | | aralkylamino compound; imidazoles | histamine agonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
perfosfamide | | nitrogen mustard; organochlorine compound; peroxol; phosphorodiamide | alkylating agent; antineoplastic agent; drug allergen; immunosuppressive agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
castanospermine | | indolizidine alkaloid | anti-HIV-1 agent; anti-inflammatory agent; EC 3.2.1.* (glycosidase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pravastatin | | 3-hydroxy carboxylic acid; carbobicyclic compound; carboxylic ester; hydroxy monocarboxylic acid; secondary alcohol; statin (semi-synthetic) | anticholesteremic drug; environmental contaminant; metabolite; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methyl-2-butenal | | enal | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl 3-hydroxybutyrate | | fatty acid ethyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,5-dimethyl-3-hydroxy-2(5h)-furanone | | butenolide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methylnicotinamide | | pyridinecarboxamide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-aminoisobutyric acid | | amino acid zwitterion; beta-amino acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
platanic acid | | hydroxy monocarboxylic acid; methyl ketone; pentacyclic triterpenoid | anti-HIV agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2'-deoxyuridylic acid | | deoxyuridine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate | Escherichia coli metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gallocatechol | | gallocatechin | antioxidant; metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-methylinosine | | inosines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydrobetulinic acid | | hydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-HIV agent; antileishmanial agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bergenin | | trihydroxybenzoic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxyestradiol | | 17beta-hydroxy steroid; 3-hydroxy steroid | angiogenesis modulating agent; antimitotic; antineoplastic agent; human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3'-cmp | | cytidine 3'-phosphate; pyrimidine ribonucleoside 3'-monophosphate | Escherichia coli metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xanthoxyletin | | coumarins | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pinocembrin | | (2S)-flavan-4-one; dihydroxyflavanone | antineoplastic agent; antioxidant; metabolite; neuroprotective agent; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
orsellinic acid | | dihydroxybenzoic acid; resorcinols | fungal metabolite; marine metabolite; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoimperatorin | | psoralens | EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rotenolone | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
seselin | | coumarins | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
perillene | | furans; monoterpenoid | fragrance; metabolite; semiochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycine methyl ester | | glycinyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexadecanamide | | primary fatty amide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzocyclobutene | | carbobicyclic compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9-methyladenine | | methyladenine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n'-methyl-2-pyridone-5-carboxamide | | methylpyridines; pyridinecarboxamide; pyridone | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-dimethyluracil | | pyrimidone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methoxysalicylic acid | | methoxysalicylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-dimethyluric acid | | oxopurine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucyltyrosine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylxanthine | | 3-methylxanthine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucyl-glycyl-glycine | | tripeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetylleucine | | L-leucine derivative; N-acetyl-L-amino acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-benzoylalanine, (dl-ala)-isomer | | alanine derivative; N-acyl-amino acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dipropylacetamide | | fatty amide | geroprotector; metabolite; teratogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
masoprocol | | nordihydroguaiaretic acid | antineoplastic agent; hypoglycemic agent; lipoxygenase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-methyladenine | | methyladenine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetylisoniazid | | carbohydrazide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
illimaquinone | | monohydroxy-1,4-benzoquinones; prenylquinone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
coptisine | | alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
betulin | | diol; pentacyclic triterpenoid | analgesic; anti-inflammatory agent; antineoplastic agent; antiviral agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
narciclasine | | phenanthridines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lividomycin | | lividomycins | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dmp 323 | | diazepanone; ureas | anti-HIV agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eupolauridine | | naphthyridine derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zaluzanin C | | gamma-lactone; guaiane sesquiterpenoid; organic heterotricyclic compound; secondary alcohol; sesquiterpene lactone | EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-aminonicotinic acid | | aminonicotinic acid; aminopyridine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(-)-catechin | | catechin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dehydrocostus lactone | | gamma-lactone; guaiane sesquiterpenoid; organic heterotricyclic compound; sesquiterpene lactone | antimycobacterial drug; antineoplastic agent; apoptosis inducer; cyclooxygenase 2 inhibitor; metabolite; trypanocidal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Tormentic acid | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pinobanksin | | secondary alpha-hydroxy ketone; trihydroxyflavanone | antimutagen; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sigmoidin a | | 4'-hydroxyflavanones; tetrahydroxyflavanone | anti-inflammatory agent; anti-obesity agent; antibacterial agent; metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xanthosine 5'-triphosphate | | purine ribonucleoside 5'-monophosphate; xanthosine 5'-phosphate | Escherichia coli metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monotropein | | beta-D-glucoside; cyclopentapyran; iridoid monoterpenoid; monocarboxylic acid; monosaccharide derivative | anti-inflammatory agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycyl-histidyl-lysine | | tripeptide | chelator; hepatoprotective agent; metabolite; vulnerary | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
homoeriodictyol | | 3'-methoxyflavanones; 4'-hydroxyflavanones; monomethoxyflavanone; trihydroxyflavanone | flavouring agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arjunolic acid | | hydroxy monocarboxylic acid; pentacyclic triterpenoid | antibacterial agent; antifungal agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxazolidin-2-one | | carbamate ester; oxazolidinone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monoethyl phthalate | | ethyl ester; phthalic acid monoester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylimidazoleacetic acid | | imidazoles; monocarboxylic acid | GABA agonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-aminoethyl)pyridine | | aminoalkylpyridine; primary amine | histamine agonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xanthurenic acid 8-methyl ether | | aromatic ether; monohydroxyquinoline; quinolinemonocarboxylic acid | carcinogenic agent; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl orsellinate | | hydroxybenzoic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,2-di(4-methacryloxyphenyl)propane | | bisphenol; enoate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sofosbuvir | | aminopyrimidine; aromatic carboxylic acid; nucleobase analogue; pyrimidone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methyluracil | | nucleobase analogue; pyrimidone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-methylcytosine | | aminopyrimidine; methylcytosine; pyrimidone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucyl-alanine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucyl-leucyl-leucine | | tripeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxyphenylethanol | | catechols; primary alcohol | antineoplastic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,7-dimethyluric acid | | oxopurine | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alanylproline | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
d-biotin-d-sulfoxide | | biotins; sulfoxide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
biotin sulfone | | biotins; sulfone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
asperuloside | | acetate ester; beta-D-glucoside; gamma-lactone; iridoid monoterpenoid; monosaccharide derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
primin | | 1,4-benzoquinones | allergen; antifeedant; antimicrobial agent; hapten; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(hydroxymethyl)anthraquinone | | anthraquinone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tyrosylleucine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
o-methylserine | | L-serine derivative; non-proteinogenic L-alpha-amino acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cinchonine | | (8xi)-cinchonan-9-ol; cinchona alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aucubin | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
catalpol | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxyphenylglycol | | catechols; tetrol | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methylhistamine | | aralkylamino compound; imidazoles | histamine agonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methylhippuric acid | | N-acylglycine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taraxerol | | pentacyclic triterpenoid; secondary alcohol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-peltatin | | furonaphthodioxole; gamma-lactone; lignan; organic heterotetracyclic compound; phenols | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-acetyllupeol | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lupenone | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycyltryptophan | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monocerin | | hydroxybenzoic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propionyl-coenzyme a | | acyl-CoA | Escherichia coli metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-hydroxyisocaproic acid | | 2-hydroxy fatty acid; branched-chain fatty acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
totarol | | diterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taraxerone | | scalarane sesterterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prunin protein, prunus | | (2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; flavanone 7-O-beta-D-glucoside; monosaccharide derivative | antibacterial agent; antilipemic drug; hypoglycemic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uvaol | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycyltyrosine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycylleucine | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alanyltyrosine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycyl-l-phenylalanine | | dipeptide zwitterion; dipeptide | human metabolite; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
digoxigenin-mono(digitoxoside) | | cardenolide glycoside; digitoxoside; monosaccharide derivative; steroid saponin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiazolidine-4-carboxylic acid, (r)-isomer | | thiazolidinemonocarboxylic acid; thioproline | geroprotector; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,6-dihydrothymine | | pyrimidone | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dehydroabietic acid | | abietane diterpenoid; carbotricyclic compound; monocarboxylic acid | allergen; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
palmitone | | dialkyl ketone | anticonvulsant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-methylthymine | | methylthymine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
imidazoleacetic acid | | imidazoles; monocarboxylic acid | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-methylguanosine | | methylguanosine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alanylphenylalanine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
murrayanine | | carbazoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
girinimbine | | carbazoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tryptophylglycine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
canthin-6-one | | enone; indole alkaloid; organic heterotetracyclic compound | antimycobacterial drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycylaspartic acid | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methylhippuric acid | | N-acylglycine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
delta(9)-tetrahydrocannabinolic acid | | benzochromene; diterpenoid; hydroxy monocarboxylic acid; phytocannabinoid; polyketide | anti-inflammatory agent; biomarker; metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylhippuric acid | | N-acylglycine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-glycylglutamic acid | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-caproylglycine | | N-acylglycine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diosgenin | | 3beta-sterol; hexacyclic triterpenoid; sapogenin; spiroketal | antineoplastic agent; antiviral agent; apoptosis inducer; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-2-aminoethyl cysteine | | L-cysteine thioether; non-proteinogenic L-alpha-amino acid | EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor; metabolite; protein synthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxycyclophosphamide | | nitrogen mustard; organochlorine compound; phosphorodiamide | alkylating agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-glutamyltryptophan | | dipeptide | angiogenesis modulating agent; antineoplastic agent; immunomodulator; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
malabaricone c | | butanone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
loliolide | | benzofurans | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tuberostemonine | | alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrrole-3-carboxylic acid | | pyrrolecarboxylic acid | metabolite; Penicillium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
histidylglycine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
histidinoalanine | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cinchonidine | | (8xi)-cinchonan-9-ol; cinchona alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quillaic acid | | aldehyde; hydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
p-methoxy-n-methylphenethylamine | | aromatic ether; secondary amino compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ecgonine methyl ester | | methyl ester; tertiary amino compound; tropane alkaloid | analgesic; central nervous system depressant; metabolite; mouse metabolite; opioid analgesic; peripheral nervous system drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylcytidine | | acetamides; cytidines; secondary carboxamide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxydebrisoquin | | carboxamidine; isoquinolines; secondary alcohol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hypotaurine | | aminosulfinic acid; zwitterion | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hc toxin | | homodetic cyclic peptide; tetrapeptide | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor; metabolite; phytotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epicatechin gallate | | catechin; gallate ester; polyphenol | EC 3.2.1.1 (alpha-amylase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
versiconal hemiacetal acetate | | acetate ester; anthrafuran; lactol; palmitoyl amino acid; polyphenol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
selenodiglutathione | | glutathione derivative; thioselenide | Escherichia coli metabolite; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
coprine | | cyclopropanes; dicarboxylic acid monoamide; L-glutamine derivative; non-proteinogenic L-alpha-amino acid | EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; metabolite; mycotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid ii | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
exp3174 | | biphenylyltetrazole; imidazoles; organochlorine compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ribonolactone | | butan-4-olide; ribonolactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulfamethoxazole hydroxylamine | | isoxazoles; sulfonamide | allergen; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
androsterone glucuronide | | beta-D-glucosiduronic acid; steroid glucosiduronic acid | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tephrosin | | aromatic ether; cyclic ketone; organic heteropentacyclic compound; rotenones | antineoplastic agent; metabolite; pesticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sapintoxin d | | phorbol ester; tertiary alpha-hydroxy ketone | fluorescent probe; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amarogentin | | monosaccharide derivative; secoiridoid glycoside | EC 5.99.1.2 (DNA topoisomerase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taraxasterol | | pentacyclic triterpenoid; secondary alcohol | anti-inflammatory agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
asiatic acid | | monocarboxylic acid; pentacyclic triterpenoid; triol | angiogenesis modulating agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flavoglaucin | | hydroquinones | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(6-hydroxy-2-isopropenyl-1-benzofuran-5-yl)-1-ethanone | | benzofurans | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dioscin | | hexacyclic triterpenoid; spiroketal; spirostanyl glycoside; trisaccharide derivative | anti-inflammatory agent; antifungal agent; antineoplastic agent; antiviral agent; apoptosis inducer; EC 1.14.18.1 (tyrosinase) inhibitor; hepatoprotective agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
maculosin | | dipeptide; homodetic cyclic peptide; phenols; pyrrolopyrazine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(4)-methylcytosine | | aminopyrimidine; methylcytosine; pyrimidone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylputrescine | | N-monoacetylalkane-alpha,omega-diamine; N-substituted putrescine | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4'-demethylpodophyllotoxin | | furonaphthodioxole; organic heterotetracyclic compound; phenols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lysicamine | | alkaloid antibiotic; oxoaporphine alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
celastrol | | monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procyanidin b2 | | biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aromadedrin | | 4'-hydroxyflavanones; dihydroflavonols; secondary alpha-hydroxy ketone; tetrahydroxyflavanone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylthymine | | methylthymine; pyrimidone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tyrosyl-glycyl-glycine | | tripeptide zwitterion; tripeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclic adp-ribose | | cyclic purine nucleotide; nucleotide-sugar | metabolite; ryanodine receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycylglutamine | | dipeptide zwitterion; dipeptide | metabolite; protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alanylglutamine | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
naadp | | nicotinic acid dinucleotide | calcium channel agonist; metabolite; signalling molecule | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procyanidin b5 | | biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
proanthocyanidin a2 | | hydroxyflavan; proanthocyanidin | angiogenesis modulating agent; anti-HIV agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydrosanguinarine | | benzophenanthridine alkaloid | antifungal agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tetrahydrocurcumin | | beta-diketone; diarylheptanoid; polyphenol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eriodictyol 7-glucuronide | | 3'-hydroxyflavonoid; beta-D-glucosiduronic acid | EC 1.1.1.21 (aldehyde reductase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-lipotropin, gln(9)- | | catechols; crown compound; macrocyclic lactone | bacterial metabolite; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-nitrososulfamethoxazole | | isoxazoles; nitroso compound; sulfonamide | allergen; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
protosappanin a | | catechols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,3'-neotrehalosadiamine | | amino disaccharide; glycosyl glycoside derivative | antimicrobial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salvinorin a | | organic heterotricyclic compound; organooxygen compound | metabolite; oneirogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyanidin | | 5-hydroxyanthocyanidin | antioxidant; metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
yakuchinone-a | | ketone; monomethoxybenzene; phenols | antineoplastic agent; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
marsupsin | | 1-benzofurans; aromatic ether; polyphenol | antilipemic drug; hypoglycemic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6,6'-bieckol | | aromatic ether; oxacycle; phlorotannin | anti-HIV-1 agent; metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylcytosine | | aminopyrimidine; methylcytosine; pyrimidone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eckol | | phlorotannin | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procyanidin b3 | | biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin | anti-inflammatory agent; antioxidant; EC 2.3.1.48 (histone acetyltransferase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aclacinomycin | | aminoglycoside; anthracycline; deoxy hexoside; methyl ester; monosaccharide derivative; phenols; polyketide; tertiary alcohol; tetracenequinones; zwitterion | antimicrobial agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalanylarginine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prolylarginine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methoxytryptophan | | L-alpha-amino acid zwitterion; L-tryptophan derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalanylglutamate | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aspartylglycine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aspartylglutamate | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxypipecolic acid | | piperidinemonocarboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prolyl-tyrosine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
histidylproline | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalanyl-glycyl-glycine | | tripeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucylarginine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pendolmycin | | indoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
atractylenolide iii | | naphthofuran | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
malvidin | | 5-hydroxyanthocyanidin | biological pigment; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxytryptoline | | beta-carbolines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
perlolyrine | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
endocrocin | | monocarboxylic acid; phenols; trihydroxyanthraquinone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulochrin | | benzophenones; carboxylic ester; phenols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
i-677 | | L-serine derivative; non-proteinogenic L-alpha-amino acid | antimetabolite; antimicrobial agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isohomovanillic acid | | aromatic ether; phenols; phenylacetic acids | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-amino-2-methoxypyrimidine | | aminopyrimidine; aromatic ether; methylcytosine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
asimilobine | | aporphine alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid D | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leukodopachrome | | hydroxy monocarboxylic acid; indoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ampelopsin | | dihydromyricetin; secondary alpha-hydroxy ketone | antineoplastic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pinusolide | | diterpene lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4,5-trihydroxypentanoic acid gamma-lactone | | ribonolactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxysitosterol | | 3beta-hydroxy-Delta(5)-steroid; 7alpha-hydroxy steroid | metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
jolkinolide a | | diterpene lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
jolkinolide b | | diterpene lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-o-hexadecyl-2-lyso-glycero-3-phosphorylcholine | | 1-alkyl-sn-glycero-3-phosphocholine; lysophosphatidylcholine O-16:0 | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isovitexin | | C-glycosyl compound; trihydroxyflavone | EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dopamine quinone | | 1,2-benzoquinones; primary amino compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
platycodin d | | triterpenoid saponin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
frenolicin b | | benzoisochromanequinone; p-quinones | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-oxopentanal | | ketoaldehyde | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
my 12-62c | | monohydroxyquinoline; quinolone | antibacterial agent; iron chelator; metabolite; signalling molecule | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxyphenylpyruvic acid | | 2-oxo monocarboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
proximadiol | | eudesmane sesquiterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid c | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylacetyl-coenzyme a | | acyl-CoA | Escherichia coli metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taxusin | | acetate ester; carbotricyclic compound; taxane diterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
confertin | | cyclic ketone; gamma-lactone; organic heterotricyclic compound; pseudoguaianolide | anti-inflammatory agent; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-methylcrotonylglycine | | N-acylglycine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tracheloside | | glycoside; lignan | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
maytenonic acid | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procyanidin C1 | | hydroxyflavan; polyphenol; proanthocyanidin | anti-inflammatory agent; antioxidant; EC 1.17.3.2 (xanthine oxidase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; lipoxygenase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methyleneindolenine | | indoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isopulegol | | p-menthane monoterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kadsurin | | tannin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lysylproline | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-o-methylembelin | | enol ether; monohydroxy-1,4-benzoquinones | antileishmanial agent; antineoplastic agent; hepatitis C protease inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydrodaidzein | | hydroxyisoflavanone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4'-o-methylepigallocatechin | | catechin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
corynoline | | benzophenanthridine alkaloid; cyclic acetal; isoquinolines; organic heterohexacyclic compound; secondary alcohol | antineoplastic agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; hepatoprotective agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
limonin | | epoxide; furans; hexacyclic triterpenoid; lactone; limonoid; organic heterohexacyclic compound | inhibitor; metabolite; volatile oil component | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dichamanetin | | diarylheptanoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
brevianamide f | | dipeptide; indoles; pyrrolopyrazine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ergolide | | acetate ester; cyclic ketone; gamma-lactone; organic heterotricyclic compound; sesquiterpene lactone | anti-inflammatory agent; antineoplastic agent; metabolite; NF-kappaB inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-sulfocatechol | | dihydroxybenzenesulfonic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
histidylleucine | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-methoxyheptaphylline | | carbazoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalanylserine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phellamurin | | 4'-hydroxyflavanones; beta-D-glucoside; dihydroflavonols; flavanone glycoside; monosaccharide derivative; trihydroxyflavanone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prolylglutamic acid | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nantenine | | oxoaporphine alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydrastine | | isoquinolines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butyrylcarnitine | | O-butanoylcarnitine; saturated fatty acyl-L-carnitine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxyestradiol | | 17beta-hydroxy steroid; 2-hydroxy steroid | carcinogenic agent; human metabolite; metabolite; mouse metabolite; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aromaticin | | cyclic ketone; gamma-lactone; organic heterotricyclic compound; sesquiterpene lactone | anti-inflammatory agent; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acivicin | | isoxazoles; non-proteinogenic L-alpha-amino acid; organochlorine compound | antileishmanial agent; antimetabolite; antimicrobial agent; antineoplastic agent; EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor; glutamine antagonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methylcorydaldine | | quinolone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-3,3-dimethylbutanoic acid | | non-proteinogenic alpha-amino acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pentabromopseudilin | | pyrroles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rocaglamide | | monocarboxylic acid amide; monomethoxybenzene; organic heterotricyclic compound | antileishmanial agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dentatin | | coumarins | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acronine | | acridone derivatives; alkaloid | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
enmein | | delta-lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-aminonicotinic acid | | aminonicotinic acid; aminopyridine; aromatic amine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pomolic acid | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aglafoline | | methyl ester; organic heterotricyclic compound | metabolite; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isomaltose | | glycosylglucose | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deoxyglucose | | 2-deoxy-D-glucose | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vestitone | | (3R)-2'-hydroxyisoflavanones; hydroxyisoflavanone; methoxyisoflavanone | antibacterial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pantetheine | | pantetheines; thiol | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salicin | | aromatic primary alcohol; aryl beta-D-glucoside; benzyl alcohols | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taxifolin | | taxifolin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-formylmethionine | | L-methionine derivative; N-formyl amino acid; proteinogenic amino acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fucose | | deoxygalactose | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
saponarin | | C-glycosyl compound; dihydroxyflavone; glycosyloxyflavone; monosaccharide derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hippeastrine | | delta-lactone; indole alkaloid; organic heteropentacyclic compound; secondary alcohol | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyanidin 3-o-beta-d-glucopyranoside | | anthocyanin cation; beta-D-glucoside; monosaccharide derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
silychristin | | 1-benzofurans; aromatic ether; flavonolignan; polyphenol; secondary alpha-hydroxy ketone | lipoxygenase inhibitor; metabolite; prostaglandin antagonist; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
peonidin | | 5-hydroxyanthocyanidin | antineoplastic agent; antioxidant; apoptosis inducer; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
convallatoxin | | 14beta-hydroxy steroid; 19-oxo steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; steroid aldehyde; steroid lactone | metabolite; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
furostanol i | | beta-D-glucoside; cyclic hemiketal; pentacyclic triterpenoid; steroid saponin; trisaccharide derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
decursinol | | cyclic ether; delta-lactone; organic heterotricyclic compound; secondary alcohol | analgesic; antineoplastic agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
abyssinone v | | 4'-hydroxyflavanones; phenols; trihydroxyflavanone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
davidigenin | | dihydrochalcones; polyphenol | anti-allergic agent; anti-asthmatic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
farrerol | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
naringin | | (2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; neohesperidoside | anti-inflammatory agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isonaringin | | (2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; rutinoside | anti-inflammatory agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cleomiscosin a | | aromatic ether; delta-lactone; organic heterotricyclic compound; phenols; primary alcohol | anti-inflammatory agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vicenin ii | | C-glycosyl compound; trihydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eugeniin | | beta-D-glucoside; ellagitannin; gallate ester; lactone | anti-HSV-1 agent; antifungal agent; antineoplastic agent; EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
knipholone | | aromatic ketone; dihydroxyanthraquinone; methoxybenzenes; methyl ketone; polyphenol; resorcinols | antineoplastic agent; antioxidant; antiplasmodial drug; leukotriene antagonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha bitter acid | | aromatic ketone; cyclic ketone; diketone; tertiary alpha-hydroxy ketone; triol | antibacterial drug; antioxidant; cyclooxygenase 2 inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acanthoside b | | beta-D-glucoside | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorpromazine n-oxide | | organochlorine compound; phenothiazines; tertiary amine oxide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxyaspartic acid, (threo-l)-isomer | | 3-hydroxy-L-aspartic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclo(l-phe-l-pro) | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyochelin | | monocarboxylic acid; phenols; thiazolidines | metabolite; siderophore | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
surfactin c | | cyclodepsipeptide; lipopeptide antibiotic; macrocyclic lactone | antibacterial agent; antifungal agent; antineoplastic agent; antiviral agent; metabolite; platelet aggregation inhibitor; surfactant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
petunidin-3-glucoside | | anthocyanin cation; aromatic ether; beta-D-glucoside | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
malvidin-3-glucoside | | anthocyanin cation; aromatic ether; beta-D-glucoside | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dioncophylline a | | biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes; naphthalenes | antifungal agent; antimalarial; metabolite; molluscicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dioncophylline c | | aromatic ether; biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes; naphthols | antimalarial; antiplasmodial drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
latrunculin a | | cyclic hemiketal; macrolide; oxabicycloalkane; thiazolidinone | actin polymerisation inhibitor; metabolite; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aglucovancomycin b | | cyclic ether; heterodetic cyclic peptide; peptide antibiotic; peptide zwitterion; polyphenol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(S)-ATPA | | isoxazoles; non-proteinogenic L-alpha-amino acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epothilone a | | epothilone; epoxide | antineoplastic agent; metabolite; microtubule-stabilising agent; tubulin modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alitretinoin | | retinoic acid | antineoplastic agent; keratolytic drug; metabolite; retinoid X receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoleucylvaline | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
afimoxifene | | phenols; tertiary amino compound | antineoplastic agent; estrogen receptor antagonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxyhippuric acid | | N-acylglycine; phenols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
12-deoxyphorbol 13-acetate | | phorbol ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
conidendrin | | lignan | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bevirimat | | dicarboxylic acid monoester; monocarboxylic acid; pentacyclic triterpenoid | HIV-1 maturation inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azaserine | | carboxylic ester; diazo compound; L-serine derivative; non-proteinogenic L-alpha-amino acid | antifungal agent; antimetabolite; antimicrobial agent; antineoplastic agent; glutamine antagonist; immunosuppressive agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
16beta,17-dihydroxy-ent-kaurane-19-oic acid | | bridged compound; diol; ent-kaurane diterpenoid; hydroxy monocarboxylic acid; primary alcohol; tertiary alcohol | anti-HIV agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycyrin | | aromatic ether; coumarins; hydroxyisoflavans | antibacterial agent; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
reynosin | | organic heterotricyclic compound; sesquiterpene lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
moronic acid | | pentacyclic triterpenoid | anti-HIV agent; anti-HSV-1 agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
maltitol | | alpha-D-glucoside; glycosyl alditol | laxative; metabolite; sweetening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Phe-Tyr | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-acetyl-1-pyrroline | | acylimine; methyl ketone; pyrroline | flavouring agent; Maillard reaction product; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl indole-3-carboxylate | | indoles; methyl ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
camalexin | | 1,3-thiazoles; indole phytoalexin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
komaroviquinone | | bridged compound; lactol; p-quinones; tetracyclic diterpenoid | metabolite; trypanocidal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxycinnamic acid | | 2-coumaric acid; phenols | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
16-epivincamine | | alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diethyl fumarate | | diester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoliquiritigenin | | chalcones | antineoplastic agent; biological pigment; EC 1.14.18.1 (tyrosinase) inhibitor; GABA modulator; geroprotector; metabolite; NMDA receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-acetyl-beta-carboline | | harmala alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propolin c | | 4'-hydroxyflavanones; tetrahydroxyflavanone | metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xanthohumol | | aromatic ether; chalcones; polyphenol | anti-HIV-1 agent; antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butylidenephthalide | | 2-benzofurans; gamma-lactone | EC 3.2.1.20 (alpha-glucosidase) inhibitor; hypoglycemic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
malonyl coenzyme a | | malonyl-CoAs | EC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor; Escherichia coli metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
imidazol-1-ylacetic acid | | imidazolyl carboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
captax | | aryl thiol; benzothiazoles | carcinogenic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetyltryptophan | | L-tryptophan derivative; N-acetyl-L-amino acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cinnamoylglycine | | N-acylglycine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-benzoylalanine | | N-acyl-L-alanine; N-benzoylalanine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoferulic acid | | ferulic acids | antioxidant; biomarker; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxypeucadanin, (r)-(+)-isomer | | furanocoumarin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
curcumin | | aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol | anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiouracil | | nucleobase analogue; thiocarbonyl compound | antithyroid drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
allylthiourea | | thioureas | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-glycylalanine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
caryophyllene oxide | | epoxide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fumonisin b1 | | diester; fumonisin; primary amino compound; triol | carcinogenic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
olivetolic acid | | benzoic acids; monocarboxylic acid; polyketide; resorcinols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hirsutine, (16e,20beta)-isomer | | alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Ganodermanontriol | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dieckol | | aromatic ether; oxacycle; phlorotannin | anticoagulant; EC 3.2.1.20 (alpha-glucosidase) inhibitor; hepatoprotective agent; metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycylproline | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tamoxifen n-oxide | | aromatic ether; tertiary amine oxide | anti-estrogen; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-deacetylgedunin | | cyclic terpene ketone; delta-lactone; enone; epoxide; furans; limonoid; pentacyclic triterpenoid | anti-inflammatory agent; antimalarial; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
galactose-6-phosphate | | D-galactose 6-phosphate | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nicotine n-glucuronide | | iminium betaine; N-glycosylpyridine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isorhyncophylline | | indolizines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cysteinylproline | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycyllysine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methionyltryptophan | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ascorbigen | | indolyl carbohydrate | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pimeloyl-coenzyme a | | omega-carboxyacyl-CoA | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-salicylate glucuronide | | benzoic acids; beta-D-glucosiduronic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoschaftoside | | C-glycosyl compound; trihydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
croomine | | alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-hydroxyflavanone | | 3'-hydroxyflavanones; monohydroxyflavanone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ungeremine | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
seryl-proline | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxy-5-methyl-3(2h)-furanone | | cyclic ketone; enol; furans | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
annomontine | | alkaloid; aminopyrimidine; beta-carbolines | antiparasitic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-hydroxymanzamine a | | alkaloid; beta-carbolines; isoquinolines | anti-HSV-2 agent; EC 2.7.11.26 (tau-protein kinase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ginkgetin | | biflavonoid; hydroxyflavone; methoxyflavone; ring assembly | anti-HSV-1 agent; antineoplastic agent; cyclooxygenase 2 inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
calceolarioside b | | hydroxycinnamic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eupatilin | | dihydroxyflavone; trimethoxyflavone | anti-inflammatory agent; anti-ulcer drug; antineoplastic agent; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin 3-o-glucuronide | | beta-D-glucosiduronic acid; quercetin O-glycoside | antidepressant; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
australifungin | | carbobicyclic compound; enol; enone; secondary alcohol | antifungal agent; EC 2.3.1.24 (sphingosine N-acyltransferase) inhibitor; HIV-1 integrase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
catechin gallate | | flavans; gallate ester; polyphenol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sterigmatocystin | | sterigmatocystins | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,7-dimethoxy-5,3',4'-trihydroxyflavone | | dimethoxyflavone; trihydroxyflavone | EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
apigenin | | trihydroxyflavone | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,3'-dihydroxy-4'-methoxyisoflavone | | 4'-methoxyisoflavones; 7-hydroxyisoflavones | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
calcitriol | | D3 vitamins; hydroxycalciol; triol | antineoplastic agent; antipsoriatic; bone density conservation agent; calcium channel agonist; calcium channel modulator; hormone; human metabolite; immunomodulator; metabolite; mouse metabolite; nutraceutical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vomifoliol | | (6S)-vomifoliol | metabolite; phytotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
feruloyltyramine | | tyramines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
luteolin-7-glucuronide | | glycosyloxyflavone; luteolin O-glucuronoside; monosaccharide derivative; trihydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chrysoeriol | | monomethoxyflavone; trihydroxyflavone | antineoplastic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin 3-o-methyl ether | | monomethoxyflavone; tetrahydroxyflavone | antimicrobial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dexmedetomidine | | trihydroxyflavone; trimethoxyflavone | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
apigetrin | | beta-D-glucoside; dihydroxyflavone; glycosyloxyflavone; monosaccharide derivative | antibacterial agent; metabolite; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rutin | | disaccharide derivative; quercetin O-glucoside; rutinoside; tetrahydroxyflavone | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-ketoprostaglandin e1 | | prostaglandins E | metabolite; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lipoxin a4 | | hydroxy polyunsaturated fatty acid; lipoxin; long-chain fatty acid | human metabolite; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
harmine | | harmala alkaloid | anti-HIV agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
naringenin chalcone | | chalcones; polyphenol | anti-allergic agent; anti-inflammatory agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cornexistin | | cyclic dicarboxylic anhydride; organic heterobicyclic compound; secondary alpha-hydroxy ketone | herbicide; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isobavachalcone | | chalcones; polyphenol | antibacterial agent; metabolite; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
daphnoretin | | aromatic ether; hydroxycoumarin | antineoplastic agent; antiviral agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Rhynchophylline | | indolizines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
esculin | | beta-D-glucoside; hydroxycoumarin | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mammeisin | | neoflavonoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ostruthin | | terpene lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
costunolide | | germacranolide; heterobicyclic compound | anthelminthic drug; antiinfective agent; antineoplastic agent; antiparasitic agent; antiviral drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
caryophyllene | | beta-caryophyllene | fragrance; insect attractant; metabolite; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phaseic acid | | alpha,beta-unsaturated monocarboxylic acid; apo carotenoid sesquiterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
agathisflavone | | biaryl; biflavonoid; hydroxyflavone | antineoplastic agent; antiviral agent; hepatoprotective agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cupressuflavone | | biflavonoid; hydroxyflavone; ring assembly | EC 3.4.21.37 (leukocyte elastase) inhibitor; metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fisetin | | 3'-hydroxyflavonoid; 7-hydroxyflavonol; tetrahydroxyflavone | anti-inflammatory agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
genkwanin | | dihydroxyflavone; monomethoxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bellidifolin | | polyphenol; xanthones | EC 3.1.1.7 (acetylcholinesterase) inhibitor; hypoglycemic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
demethylbellidifolin | | tetrol; xanthones | antioxidant; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite; mutagen; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hinokiflavone | | aromatic ether; biflavonoid; hydroxyflavone | antineoplastic agent; metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
euxanthone | | phenols; xanthones | metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylquercetin | | 7-hydroxyflavonol; monomethoxyflavone; tetrahydroxyflavone | anticoagulant; EC 1.14.18.1 (tyrosinase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norswertianolin | | beta-D-glucoside; xanthones | EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
swerchirin | | aromatic ether; phenols; xanthones | hypoglycemic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoscutellarein | | tetrahydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kaempferide | | 7-hydroxyflavonol; monomethoxyflavone; trihydroxyflavone | antihypertensive agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
morin | | 7-hydroxyflavonol; pentahydroxyflavone | angiogenesis modulating agent; anti-inflammatory agent; antibacterial agent; antihypertensive agent; antineoplastic agent; antioxidant; EC 5.99.1.2 (DNA topoisomerase) inhibitor; hepatoprotective agent; metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norwogonin | | trihydroxyflavone | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
orientin | | 3'-hydroxyflavonoid; C-glycosyl compound; tetrahydroxyflavone | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
patuletin | | flavonols; monomethoxyflavone; pentahydroxyflavone | analgesic; antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rhamnetin | | monomethoxyflavone; tetrahydroxyflavone | anti-inflammatory agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
robustaflavone | | biflavonoid; hydroxyflavone; ring assembly | anti-HBV agent; antineoplastic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
scutellarein | | tetrahydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tricetin | | pentahydroxyflavone | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tricin | | 3'-methoxyflavones; dimethoxyflavone; trihydroxyflavone | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
astringin | | beta-D-glucoside; monosaccharide derivative; polyphenol; stilbenoid | antineoplastic agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
polydatin | | beta-D-glucoside; monosaccharide derivative; polyphenol; stilbenoid | anti-arrhythmia drug; antioxidant; geroprotector; hepatoprotective agent; metabolite; nephroprotective agent; potassium channel modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epsilon-viniferin | | 1-benzofurans; polyphenol; stilbenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
irilone | | hydroxyisoflavone; organic heterotricyclic compound; oxacycle | antineoplastic agent; immunomodulator; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
caffeic acid phenethyl ester | | alkyl caffeate ester | anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; antiviral agent; immunomodulator; metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
licoisoflavone a | | 7-hydroxyisoflavones | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prunetin | | 7-methoxyisoflavones; hydroxyisoflavone | anti-inflammatory agent; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
wedelolactone | | aromatic ether; coumestans; delta-lactone; polyphenol | antineoplastic agent; apoptosis inducer; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; hepatoprotective agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rottlerin | | aromatic ketone; benzenetriol; chromenol; enone; methyl ketone | anti-allergic agent; antihypertensive agent; antineoplastic agent; apoptosis inducer; K-ATP channel agonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
syringetin | | 3',5'-dimethoxyflavone; 3'-methoxyflavones; 7-hydroxyflavonol; dimethoxyflavone; tetrahydroxyflavone | metabolite; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
10-deoxymethynolide | | macrolide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4',7-dihydroxyflavone | | dihydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rhoifolin | | dihydroxyflavone; glycosyloxyflavone; neohesperidoside | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
veronicastroside | | disaccharide derivative; glycosyloxyflavone; neohesperidoside; trihydroxyflavone | antibacterial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercimeritrin | | beta-D-glucoside; flavonols; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
josamycin | | acetate ester; aldehyde; disaccharide derivative; glycoside; macrolide antibiotic; tertiary alcohol; tertiary amino compound | antibacterial drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n,n-dimethylsphingenine | | aminodiol; sphingoid; tertiary amino compound | EC 2.7.1.91 (sphingosine kinase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxyestradiol | | 4-hydroxy steroid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9-hydroxy-10,12-octadecadienoic acid | | HODE; octadecadienoic acid | human metabolite; metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9-oxo-10,12-octadecadienoic acid | | enone; oxooctadecadienoic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
13-oxo-9,11-octadecadienoic acid | | 13-oxo-9,11-octadecadienoic acid; oxo fatty acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
13,14-dihydro-15-ketoprostaglandin d2 | | prostaglandins D | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
15-keto-13,14-dihydroprostaglandin f2alpha | | ketone; prostaglandins Falpha | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,3-dinor-6-ketoprostaglandin f1alpha | | 4-oxo monocarboxylic acid; prostanoid; secondary alcohol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ergosta-7,22-dien-3-ol, (3beta,5alpha,6alpha,22e)-isomer | | 3beta-sterol | anti-HSV-1 agent; antifungal agent; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
calcifediol | | D3 vitamins; diol; hydroxycalciol | bone density conservation agent; human metabolite; metabolite; mouse metabolite; nutraceutical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclosporine | | homodetic cyclic peptide | anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oleyl alcohol | | fatty alcohol 18:1; long-chain primary fatty alcohol | metabolite; nonionic surfactant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fortimicin a | | amino cyclitol glycoside; aminoglycoside antibiotic; diol; monocarboxylic acid amide; primary amino compound | antibacterial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3',4',7-trihydroxyisoflavone | | 7-hydroxyisoflavones | antineoplastic agent; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6,7,4'-trihydroxyisoflavone | | 7-hydroxyisoflavones | anti-inflammatory agent; antimutagen; EC 1.14.18.1 (tyrosinase) inhibitor; metabolite; PPARalpha agonist; PPARgamma agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
15-deoxy-delta(12,14)-prostaglandin j2 | | prostaglandins J | electrophilic reagent; insulin-sensitizing drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cytochalasin b | | cytochalasin; lactam; lactone; organic heterotricyclic compound | actin polymerisation inhibitor; metabolite; mycotoxin; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ciguatoxins | | ciguatoxin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
12-hydroxy-5,8,10-heptadecatrienoic acid | | hydroxy polyunsaturated fatty acid; long-chain fatty acid; trienoic fatty acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bisdemethoxycurcumin | | beta-diketone; diarylheptanoid; enone; polyphenol | EC 3.2.1.1 (alpha-amylase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clausine e | | carbazoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl caffeate | | alkyl caffeate ester; ethyl ester; hydroxycinnamic acid | anti-inflammatory agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
heptaphylline | | carbazoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pellitorine | | fatty amide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
andrographolide | | carbobicyclic compound; gamma-lactone; labdane diterpenoid; primary alcohol; secondary alcohol | anti-HIV agent; anti-inflammatory drug; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isorhamnetin-3-o-galactoside | | beta-D-galactoside; glycosyloxyflavone; monomethoxyflavone; monosaccharide derivative; trihydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isorhamnetin 3-o-glucoside | | beta-D-glucoside; glycosyloxyflavone; monomethoxyflavone; monosaccharide derivative; trihydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kaempferol-3-o-rutinoside | | disaccharide derivative; kaempferol O-glucoside; rutinoside; trihydroxyflavone | metabolite; plant metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ligustilide | | butenolide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,4'-dihydroxy-3'-methoxyisoflavone | | 7-hydroxyisoflavones; methoxyisoflavone | antiplasmodial drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sappanchalcone | | catechols; chalcones; monomethoxybenzene | anti-allergic agent; anti-inflammatory agent; antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl brevifolincarboxylate | | cyclic ketone; delta-lactone; organic heterotricyclic compound; phenols | EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; metabolite; platelet aggregation inhibitor; radical scavenger; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-deoxysappanchalcone | | chalcones; monomethoxybenzene; phenols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nostocarboline | | alkaloid; beta-carbolines; organic cation; organochlorine compound | antimalarial; EC 3.1.1.8 (cholinesterase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ergosterol-5,8-peroxide | | 3beta-sterol; ergostanoid; organic peroxide; phytosterols | antimycobacterial drug; antineoplastic agent; metabolite; trypanocidal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(4-hydroxy-3-methoxyphenyl)-n-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-2-propenamide | | hydroxycinnamic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
macluraxanthone b | | phenols; xanthones | anti-HIV agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flavokawain b | | chalcones; dimethoxybenzene; phenols | anti-inflammatory agent; antileishmanial agent; antineoplastic agent; apoptosis inducer; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alternariol | | benzochromenone; phenols | EC 3.1.1.8 (cholinesterase) inhibitor; metabolite; mycotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cis-3-hexenyl acetate | | acetate ester; olefinic compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pipercallosidine | | alkaloid; benzodioxoles; enamide; secondary carboxamide | apoptosis inducer; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(4-hydroxy-beta-phenethyl)-4-hydroxycinnamide | | hydroxycinnamic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-hydroxyisoflavone | | 7-hydroxyisoflavones | EC 1.14.14.14 (aromatase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flazin | | harmala alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
11-hydroxynoracronycine | | acridines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
jaceosidin | | dimethoxyflavone; trihydroxyflavone | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,7,3'-trihydroxy-3,4'-dimethoxyflavone | | dimethoxyflavone; trihydroxyflavone | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salutaridine | | morphinane alkaloid | anti-HBV agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cytochalasin e | | cytochalasan alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
artocarpin lectin | | monomethoxyflavone; trihydroxyflavone | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fumarates | | butenedioate; C4-dicarboxylate | human metabolite; metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bleomycin | | bleomycin | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,7-dihydroxy-4-methoxyxanthone | | aromatic ether; phenols; xanthones | metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
demethoxycurcumin | | beta-diketone; diarylheptanoid; enone; polyphenol | anti-inflammatory agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bergamottin | | furanocoumarin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alanyl-alanyl-alanine | | tripeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
24-ethyl-4-cholesten-3-one | | C29-steroid; steroid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
myricetin 3-o-glucuronide | | monosaccharide derivative; myricetin O-glucuronide; pentahydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalanylalanine | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpinumisoflavone | | isoflavanones | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-aspartylalanine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alanyltyrosine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arglabin | | epoxide; gamma-lactone; organic heterotetracyclic compound; sesquiterpene lactone | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ap 10 | | diterpene lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin 7-rhamnoside | | alpha-L-rhamnoside; flavonols; monosaccharide derivative; quercetin O-glycoside; tetrahydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
albonoursin | | 2,5-diketopiperazines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oroidin | | pyrroles; secondary carboxamide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monorden | | cyclic ketone; enone; epoxide; macrolide antibiotic; monochlorobenzenes; phenols | antifungal agent; metabolite; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
apratoxin a | | 1,3-thiazoles; apratoxin | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(-)-catechin-3-O-gallate | | flavans; gallate ester; polyphenol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aspartyllysine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arginyllysine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hygromycin a | | hydroxycinnamic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
latrunculin b | | cyclic hemiketal; macrolide; oxabicycloalkane; thiazolidinone | actin polymerisation inhibitor; metabolite; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
falcarindiol | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dehydroergosterol | | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; ergostanoid; phytosterols | biomarker; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-oleoylglycine | | fatty amide; N-acylglycine 18:1 | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rhizoxin | | 1,3-oxazoles; epoxide; macrolide antibiotic | antimitotic; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
manoalide | | butenolide; lactol; sesterterpenoid | EC 3.1.1.4 (phospholipase A2) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
concanamycin a | | carbamate ester; concanamycin | antifungal agent; EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid | | enoate ester; methyl ester; monocarboxylic acid amide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thunberginol f | | catechols; gamma-lactone; isobenzofuranone | metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyracrenic acid | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eicosa-11,14-dienoic acid, (z,z)-isomer | | icosadienoic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
yuanhuadine | | diterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tiglylglycine | | N-acylglycine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rhodiocyanoside a | | aliphatic nitrile; beta-D-glucoside; cyanogenic glycoside; monosaccharide derivative | anti-allergic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(2E,4E)-N-isobutyl-2,4-dodecadienamide | | fatty amide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mycothiazole | | thiazoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
13-oxo-9,11-octadecadienoic acid | | 13-oxo-9,11-octadecadienoic acid | metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
linderalactone | | butenolide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pros-methylimidazoleacetic acid | | imidazolyl carboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cellobionic acid | | carbohydrate acid; disaccharide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pseudopteroxazole | | tetralins | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sophoraflavanone a | | (2S)-flavan-4-one; 4'-hydroxyflavanones; trihydroxyflavanone | antibacterial agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
panduratin a | | diarylheptanoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
stigmasterol 3-o-beta-d-glucopyranoside | | beta-D-glucoside; monosaccharide derivative; phytosterols; steroid saponin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
17-hydroxyjolkinolide b | | diterpene lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sq-23377 | | cyclic ether; enol; polyunsaturated fatty acid; very long-chain fatty acid | calcium ionophore; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
corosolic acid | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclo(prolyl-valyl) | | piperazinone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalanylglycine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucyl-phenylalanine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glutamylalanine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glutaminyl-glycine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methionylglycine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
valylleucine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalanyl-valine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclo(glycyltryptophyl) | | indoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alanylglycine | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
valyltyrosine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-glutamyltryptophan | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lysylglutamic acid | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methionylglutamic acid | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
seryl-histidine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arginyl-glutamine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalanylproline | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lysylglycine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycylhistidine | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kopsinine | | indole alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclo(leucyl-phenylalanyl) | | 2,5-diketopiperazines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prolylisoleucine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalanyl-valine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoleucyl-tyrosine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prolyl-serine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
grayanotoxin i | | acetate ester; pentol; secondary alcohol; tertiary alcohol; tetracyclic diterpenoid | antihypertensive agent; metabolite; neuromuscular agent; phytotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
19-norandrosterone | | 17-oxo steroid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-allylcysteine | | L-alpha-amino acid zwitterion; S-hydrocarbyl-L-cysteine | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oleandrigenin | | 14beta-hydroxy steroid; 3beta-hydroxy steroid; steroid ester | EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
valyl-prolyl-proline | | tripeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prolylvaline | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
palbinone | | 16-oxo steroid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pseurotin | | azaspiro compound; lactam; oxaspiro compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gambogic acid | | pyranoxanthones | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xenovulene a | | cyclic ether; enone; organic heterotetracyclic compound; sesquiterpenoid | GABA antagonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fr 148083 | | aromatic ether; macrolide; phenols; secondary alcohol; secondary alpha-hydroxy ketone | antibacterial agent; antineoplastic agent; metabolite; NF-kappaB inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
LL-Z1640-1 | | macrolide; resorcinols | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9-methoxycanthin-6-one | | aromatic ether; indole alkaloid; organic heterotetracyclic compound | antineoplastic agent; antiplasmodial drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylcarnosine | | dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cholest-5-en-3-one | | 3-oxo-Delta(5)-steroid; cholestanoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kaempferol 3-O-beta-L-glucopyranoside | | beta-L-glucoside; flavonols; kaempferol O-glucoside; monosaccharide derivative; trihydroxyflavone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rubraxanthone | | aromatic ether; polyphenol; xanthones | antibacterial agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ubiquinol | | polyprenylhydroquinone; ubiquinol | biomarker; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
landomycin a | | oligosaccharide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ancistroealaine a | | aromatic ether; biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes | antileishmanial agent; antiplasmodial drug; metabolite; trypanocidal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cerberin | | acetate ester; cardenolide glycoside; monosaccharide derivative | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
actein | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
araloside a | | triterpenoid saponin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ageladine a | | alkaloid; aromatic amine; imidazopyridine; organobromine compound; pyrroles | angiogenesis inhibitor; antineoplastic agent; matrix metalloproteinase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
corynoxine b | | indolizines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kaempferol 7-o-glucoside | | beta-D-glucoside; flavonols; kaempferol O-glucoside; monosaccharide derivative; trihydroxyflavone | metabolite; plant metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
delphinidin 3-sambubioside | | anthocyanidin 3-O-beta-D-sambubioside | apoptosis inducer; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nodosin | | delta-lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
protylonolide | | diol; enone; macrolide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arisugacin | | aromatic ether; delta-lactone; enone; organic heterotetracyclic compound; tertiary alcohol | antimicrobial agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite; Penicillium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nymphaeol c | | 4'-hydroxyflavanones; tetrahydroxyflavanone | metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thonningianin a | | tannin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cephalostatin i | | oxo steroid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
papyriflavonol a | | 3'-hydroxyflavonoid; flavonols; pentahydroxyflavone | EC 1.14.18.1 (tyrosinase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lactonamycin | | gamma-lactone; organic heterohexacyclic compound; phenols; trideoxyhexose derivative | antibacterial agent; antimicrobial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
myrsinoic acid b | | 1-benzofurans; monocarboxylic acid | anti-inflammatory agent; EC 4.4.1.11 (methionine gamma-lyase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
betulone | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eckstolonol | | organic heteropentacyclic compound; oxacycle; phlorotannin | metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
manassantin b | | benzodioxoles; dimethoxybenzene; lignan; oxolanes; secondary alcohol | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gitaloxin | | cardenolide glycoside | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
paeonilide | | benzoate ester | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroxanthohumol | | aromatic ether; dihydrochalcones; polyphenol | EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
corynoxine | | indolizines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-phloroeckol | | aromatic ether; phlorotannin | antioxidant; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(+)-lyoniresinol-3-alpha-O-beta-D-glucopyranoside | | beta-D-glucoside; dimethoxybenzene; lignan; monosaccharide derivative; polyphenol; primary alcohol; tetralins | antibacterial agent; antifungal agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Sphaeropsidin C | | tricyclic diterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kelampayoside a | | glycoside | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5-dimethoxy-4-hydroxybenzyl alcohol-4-O-beta-D-glucopyranoside | | aromatic ether; benzyl alcohols; beta-D-glucoside; monosaccharide derivative; primary alcohol | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,3-dihydro-3beta-methoxy withaferin A | | 27-hydroxy steroid; 4-hydroxy steroid; delta-lactone; epoxy steroid; ergostanoid; primary alcohol; secondary alcohol; withanolide | metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nigranoic acid | | dicarboxylic acid; tetracyclic triterpenoid | antineoplastic agent; HIV-1 reverse transcriptase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
esculeoside a | | azaspiro compound; oxaspiro compound; saponin; steroid alkaloid; steroid saponin | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aerothionin | | isoxazoles | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
artemisic acid | | carbobicyclic compound; monocarboxylic acid; octahydronaphthalenes; sesquiterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
26-deoxyactein | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-formylcytosine | | aminopyrimidine; heteroarenecarbaldehyde; nucleobase analogue; pyrimidone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
migrastatin | | ether; macrolide antibiotic; piperidones; secondary alcohol | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Lyngbic acid | | long-chain fatty acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,3,6,8-tetrahydroxy-1-(3-methylbut-2-enyl)-5-(2-methylbut-3-en-2-yl)-9h-xanthen-9-one | | polyphenol; xanthones | anti-inflammatory agent; antineoplastic agent; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bielschowskysin | | acetate ester; cyclic acetal; diterpenoid; gamma-lactone; organic heterohexacyclic compound | antimalarial; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
procyanidin b1 | | biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin | anti-inflammatory agent; EC 3.4.21.5 (thrombin) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclo(tyrosyl-tyrosyl) | | cyclo(tyrosyl-tyrosyl) | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
spiculoic acid a | | carbobicyclic compound; cyclic ketone; oxo monocarboxylic acid; styrenes | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
myrocin a | | tertiary alcohol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3'-o-methylepicatechin | | catechin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
episilvestrol | | dioxanes; ether; methyl ester; organic heterotricyclic compound | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
protopanaxatriol | | 12beta-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; 6alpha-hydroxy steroid; sapogenin; tetracyclic triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
laurinterol | | organobromine compound; phenols; sesquiterpenoid | antibacterial agent; apoptosis inducer; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Pseudopterosin G-J aglycone | | diterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ceratamine a | | alkaloid; aromatic ether; cyclic ketone; organic heterobicyclic compound; organobromine compound; secondary amino compound; tertiary amine | antimitotic; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
liphagal | | aldehyde; cyclic ether; meroterpenoid; organic heterotetracyclic compound; polyphenol | EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pulsatilla saponin d | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diversonol | | phenols; tertiary alcohol | antibacterial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
neotuberostemonine | | alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
drymaritin | | enol ether; enone; indole alkaloid; organic heterotetracyclic compound | anti-HIV agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lyoniresinol | | dimethoxybenzene; lignan; polyphenol; primary alcohol; tetralins | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
silvestrol | | dioxanes; ether; methyl ester; organic heterotricyclic compound | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ginsenoside ro | | triterpenoid saponin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diosgenin glucoside | | hexacyclic triterpenoid; monosaccharide derivative; spiroketal; sterol 3-beta-D-glucoside | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyripyropene a | | organic heterotetracyclic compound; sesquiterpenoid | acyl-CoA:cholesterol acyltransferase 2 inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-epioleanolic acid | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucylproline | | dipeptide zwitterion; dipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
R-(-)-actinodaphnine | | aporphine alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cytotrienin a | | cyclopropanecarboxylate ester; ether; hydroquinones; lactam; macrocycle; secondary alcohol | antibacterial agent; antimicrobial agent; antineoplastic agent; apoptosis inducer; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylamphotericin b | | macrolide; methyl ester; monosaccharide derivative | antifungal agent; antiinfective agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2'-methoxykurarinone | | 4'-hydroxyflavanones; dihydroxyflavanone; dimethoxyflavanone | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
verproside | | glycoside | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
verminoside | | hydroxycinnamic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
minecoside | | hydroxycinnamic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(R)-(+)-6',7'-dihydroxybergamottin | | furanocoumarin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lapidilectine b | | indolyl carboxylic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
batzelladine a | | alkaloid; carboxylic ester; guanidines; organic heterotricyclic compound; pyrrolopyrimidine; triazaacenaphthylene | anti-HIV-1 agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alloin | | anthracenes; C-glycosyl compound; cyclic ketone; phenols | laxative; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
longipinene | | alpha-longipinene | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
parkeol | | 3beta-hydroxy-4,4-dimethylsteroid; 3beta-sterol; tetracyclic triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rutundic acid | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
a-factor (streptomyces) | | butan-4-olide; primary alcohol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taraxasteryl acetate | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chikusetsu saponin iva | | triterpenoid saponin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xestoaminol c | | amino alcohol; sphingoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
malyngamide A | | dicarboximide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
simalikalactone D | | cyclic ether; delta-lactone; enone; organic heteropentacyclic compound; quassinoid; secondary alcohol; secondary alpha-hydroxy ketone; triol | antimalarial; antineoplastic agent; antiviral agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
friedelane | | triterpene | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
shamixanthone | | cyclic ketone; phenols; pyranoxanthene | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
17,18-epoxy-5,8,11,14-eicosatetraenoic acid | | EpETE | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chaetominine | | indole alkaloid; lactam; organic heterotetracyclic compound; quinazolines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
schweinfurthin g | | cyclic ether; organic heterotricyclic compound; resorcinols; stilbenoid | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salmon calcitonin | | heterodetic cyclic peptide; peptide hormone; polypeptide | bone density conservation agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
complestatin | | cyclic ether; heterodetic cyclic peptide; indoles; organic heterobicyclic compound; organochlorine compound; peptide antibiotic; polyphenol | anti-HIV-1 agent; antimicrobial agent; HIV-1 integrase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
neuroprotectin a | | cyclic ether; heterodetic cyclic peptide; indoles; organochlorine compound; polyphenol | HIV-1 integrase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alx-0600 | | polypeptide | antioxidant; glucagon-like peptide-2 receptor agonist; metabolite; protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
schweinfurthin f | | cyclic ether; organic heterotricyclic compound; resorcinols; stilbenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
antrocamphin a | | methoxybenzenes | anti-inflammatory agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
respirantin | | benzamides; cyclodepsipeptide; formamides; phenols | antimicrobial agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
streptobiosamine | | amino disaccharide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
interiotherin b | | aromatic ether; fatty acid ester; lignan; organic heteropentacyclic compound; oxacycle | anti-HIV agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
succinyladenosine | | adenosines; amino dicarboxylic acid; L-aspartic acid derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-tuliposide a | | 6-O-acyl-D-glucose; homoallylic alcohol | allergen; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycochenodeoxycholate-3-sulfate | | 7alpha-hydroxy steroid; bile acid glycine conjugate; steroid sulfate | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
wewakazole | | cyclic peptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
spongia-13(16),14-dien-19-oic acid | | cyclic ether; monocarboxylic acid; tetracyclic diterpenoid | androgen antagonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Icariside E4 | | benzofurans | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lucidenic acid n | | cyclic terpene ketone; dioxo monocarboxylic acid; secondary alcohol; tetracyclic triterpenoid | antineoplastic agent; EC 3.1.1.8 (cholinesterase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroagarofuran | | bridged compound; cyclic ether; eudesmane sesquiterpenoid; organic heterotricyclic compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
23-epi-26-deoxyactein | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
23-hydroxybetulinic acid | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(1S,3aR,4S,6S,6aS,9aS,9bS)-9a-isocyano-6-(2-isocyano-2-methylpropyl)-1,4-dimethyl-7-methylidene-2,3,3a,4,5,6,6a,8,9,9b-decahydro-1H-phenalene | | diterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bromophycolide a | | diterpenoid; macrolide; organobromine compound; phenols; tertiary alcohol | anti-HIV agent; antibacterial agent; antifungal agent; antimalarial; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-acetamidoglucal | | acetamides; glycal derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diorcinol | | aromatic ether; phenols | fungal metabolite; marine metabolite; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
caribenol a | | organic heterotetracyclic compound; terpene lactone; tertiary alcohol | antimalarial; antitubercular agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
halisulfate 1 | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-O-feruloylcatalpol | | hydroxycinnamic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
grassypeptolide | | cyclodepsipeptide; macrocycle | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
essramycin | | triazolopyrimidines | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ainsliadimer a | | sesquiterpene lactone; spiro compound | EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salvileucalin b | | bridged compound; diterpenoid; furans; gamma-lactone | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ciliatamide a | | caprolactams; lipopeptide | antileishmanial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
etnangien | | hydroxy monocarboxylic acid; macrolide antibiotic | antibacterial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
latrunculol a | | macrolide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-trans-sinapoyltyramine | | hydroxycinnamic acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lycojapodine a | | alkaloid; bridged compound; cyclic ketone; lactone; organic heterotetracyclic compound | anti-HIV-1 agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epi-maslinic acid | | dihydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eoxin c4 | | eoxin; leukotriene | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
brartemicin | | benzoate ester; glycosyl glycoside derivative; resorcinols | antimicrobial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Majusculamide AB | | amino acid amide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,8-dihydroxyflavanone | | dihydroxyflavanone | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
antcin a | | ergostanoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
integric acid | | carboxylic ester; cyclic ketone; dioxo monocarboxylic acid; enal; enone; eremophilane sesquiterpenoid | HIV-1 integrase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vanilloloside | | glycoside | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,3-dihydro-3beta-O-sulfate withaferin A | | 27-hydroxy steroid; 4-hydroxy steroid; delta-lactone; epoxy steroid; ergostanoid; primary alcohol; steroid sulfate; withanolide | antineoplastic agent; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dicranin | | acetylenic fatty acid; long-chain fatty acid; straight-chain fatty acid; trienoic fatty acid | antibacterial agent; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leachianone a | | 4'-hydroxyflavanones; monomethoxyflavanone; trihydroxyflavanone | antimalarial; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hordatine a | | aromatic ether; benzofurans; dicarboxylic acid diamide; guanidines; phenols | adrenergic antagonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
englerin a | | cinnamate ester; glycolate ester; guaiane sesquiterpenoid | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monanchocidin | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eurycomanone | | cyclic ether; delta-lactone; enone; organic heteropentacyclic compound; pentol; quassinoid; secondary alcohol; secondary alpha-hydroxy ketone; tertiary alcohol | antimalarial; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sphaeropsidin a | | gamma-lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gardenoside | | beta-D-glucoside; cyclopentapyran; enoate ester; methyl ester; monosaccharide derivative; tertiary alcohol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
landomycin d | | anthraquinone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3alpha,12alpha-dihydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid | | 11-oxo steroid; 12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7-oxo steroid; monocarboxylic acid; secondary alpha-hydroxy ketone; steroid acid | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
antcin k | | bile acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3alpha-hydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid | | 11-oxo steroid; 3alpha-hydroxy steroid; 7-oxo steroid; monocarboxylic acid; steroid acid | antineoplastic agent; cholinergic antagonist; metabolite; serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
shizukaol B | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
shizukaol f | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
calicheamicin gamma(1)i | | calicheamicin; enediyne antibiotic; organoiodine compound | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
staphyloxanthin | | apo carotenoid triterpenoid; D-aldohexose derivative; fatty acid ester; triol; xanthophyll | antioxidant; biological pigment; metabolite; virulence factor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sm 1 peptide | | acetate ester; ergot alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mycocyclosin | | 2,5-diketopiperazines; organic heterotetracyclic compound; polyphenol | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
callipeltin a | | cyclodepsipeptide; guanidines; lactone; oligopeptide; phenols | anti-HIV-1 agent; antifungal agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vinylamycin | | cyclodepsipeptide; macrocycle; primary alcohol | antibacterial agent; antimicrobial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
promegestone | | terpene lactone | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lancifodilactone g | | cyclic ether; diol; enol; gamma-lactone; oxaspiro compound; triterpenoid | anti-HIV agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rediocide a | | diterpenoid; epoxide; ortho ester; terpene lactone | insecticide; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lasiokaurin | | kaurane diterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
longikaurin a | | kaurane diterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ponicidin | | dioxanes | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(Z)-6,6',7,3'a-Diligustilide | | butenolide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
suvanine | | organic molecular entity | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
shizukaol d | | triterpenoid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thailandepsin a | | cyclodepsipeptide | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nordidemnin b | | didemnin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-formylaminooxyvinylglycine | | non-proteinogenic alpha-amino acid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
platycoside e | | triterpenoid saponin | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leuconoxine | | alkaloid | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epidermin | | macrocycle; type A lantibiotic | antibacterial agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
surfactin A | | cyclodepsipeptide; lipopeptide antibiotic; macrocyclic lactone | antibacterial agent; antifungal agent; antineoplastic agent; antiviral agent; metabolite; surfactant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
myriaporone 3 | | beta-hydroxy ketone; epoxide; lactol; oxanes; primary alcohol; secondary alcohol | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
avenacoside b | | beta-D-glucoside; hexacyclic triterpenoid; spiroketal; steroid saponin; tetrasaccharide derivative | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methylglutarylcarnitine | | O-methylglutarylcarnitine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pivaloylcarnitine | | C5-acylcarnitine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
levoleucovorin | | 5-formyltetrahydrofolic acid | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,8-dihydroneopterin | | dihydropterin; neopterins | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guanosine monophosphate | | guanosine 5'-phosphate; purine ribonucleoside 5'-monophosphate | biomarker; Escherichia coli metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-4-oxo-6-acetyl-7,8-dihydro-3h,9h-pyrimidodiazepine | | methyl ketone; pyrimidodiazepine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dyspropterin | | biopterins; tetrahydropterin | human metabolite; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2'-o-methylguanosine | | methylguanosine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
allopurinol riboside | | nucleoside analogue | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norclozapine | | dibenzodiazepine; organochlorine compound; piperazines | delta-opioid receptor agonist; metabolite; serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-methylguanosine | | methylguanosine; organic cation | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3'-o-methylguanosine | | methylguanosine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
primapterin | | biopterins | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-methylinosine | | inosines; organic cation | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
marineosin a | | azaspiro compound; ether; macrocycle; oxaspiro compound; pyrroles | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
marineosin b | | azaspiro compound; ether; macrocycle; oxaspiro compound; pyrroles | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gallic acid | | trihydroxybenzoic acid | antineoplastic agent; antioxidant; apoptosis inducer; astringent; cyclooxygenase 2 inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; geroprotector; human xenobiotic metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydrolipoic acid | | thio-fatty acid | antioxidant; human metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydrogen | | elemental hydrogen; elemental molecule; gas molecular entity | antioxidant; electron donor; food packaging gas; fuel; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroquinone | | benzenediol; hydroquinones | antioxidant; carcinogenic agent; cofactor; Escherichia coli metabolite; human xenobiotic metabolite; mouse metabolite; skin lightening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylserotonin | | acetamides; N-acylserotonin; phenols | antioxidant; human metabolite; mouse metabolite; tropomyosin-related kinase B receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pqq cofactor | | orthoquinones; pyrroloquinoline cofactor; tricarboxylic acid | anti-inflammatory agent; antioxidant; cofactor; water-soluble vitamin (role) | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
putrescine | | alkane-alpha,omega-diamine | antioxidant; fundamental metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
spermine | | polyazaalkane; tetramine | antioxidant; fundamental metabolite; immunosuppressive agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
taurine | | amino sulfonic acid; zwitterion | antioxidant; Escherichia coli metabolite; glycine receptor agonist; human metabolite; mouse metabolite; nutrient; radical scavenger; Saccharomyces cerevisiae metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vanillin | | benzaldehydes; monomethoxybenzene; phenols | anti-inflammatory agent; anticonvulsant; antioxidant; flavouring agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isopentenyl pyrophosphate | | prenol phosphate | antigen; antioxidant; epitope; Escherichia coli metabolite; mouse metabolite; phosphoantigen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methoxytryptamine | | aromatic ether; primary amino compound; tryptamines | 5-hydroxytryptamine 2A receptor agonist; 5-hydroxytryptamine 2B receptor agonist; 5-hydroxytryptamine 2C receptor agonist; antioxidant; cardioprotective agent; human metabolite; mouse metabolite; neuroprotective agent; radiation protective agent; serotonergic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,8-dihydroxyflavone | | dihydroxyflavone | antidepressant; antineoplastic agent; antioxidant; plant metabolite; tropomyosin-related kinase B receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amifostine anhydrous | | diamine; organic thiophosphate | antioxidant; prodrug; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benphothiamine | | aminopyrimidine; formamides; organic phosphate; thioester | antioxidant; immunological adjuvant; nutraceutical; protective agent; provitamin B1 | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
caffeic acid | | catechols; hydroxycinnamic acid | antioxidant; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carcinine | | beta-alanine derivative; imidazoles; monocarboxylic acid amide; organonitrogen compound; organooxygen compound | antioxidant; crustacean metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ebselen | | benzoselenazole | anti-inflammatory drug; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 3.5.4.1 (cytosine deaminase) inhibitor; EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor; enzyme mimic; ferroptosis inhibitor; genotoxin; hepatoprotective agent; neuroprotective agent; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
idebenone | | 1,4-benzoquinones; primary alcohol | antioxidant; ferroptosis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
edaravone | | pyrazolone | antioxidant; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
molsidomine | | ethyl ester; morpholines; oxadiazole; zwitterion | antioxidant; apoptosis inhibitor; cardioprotective agent; nitric oxide donor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
masoprocol | | catechols; lignan; tetrol | antioxidant; ferroptosis inhibitor; geroprotector; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
probucol | | dithioketal; polyphenol | anti-inflammatory drug; anticholesteremic drug; antilipemic drug; antioxidant; cardiovascular drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
resveratrol | | polyphenol; resorcinols; stilbenol | antioxidant; geroprotector; glioma-associated oncogene inhibitor; phytoalexin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulforaphane | | isothiocyanate; sulfoxide | antineoplastic agent; antioxidant; EC 3.5.1.98 (histone deacetylase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
troglitazone | | chromanes; thiazolidinone | anticoagulant; anticonvulsant; antineoplastic agent; antioxidant; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; hypoglycemic agent; platelet aggregation inhibitor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zonisamide | | 1,2-benzoxazoles; sulfonamide | anticonvulsant; antioxidant; central nervous system drug; protective agent; T-type calcium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phlorhizin | | aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylene blue | | organic chloride salt | acid-base indicator; antidepressant; antimalarial; antimicrobial agent; antioxidant; cardioprotective agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 4.6.1.2 (guanylate cyclase) inhibitor; fluorochrome; histological dye; neuroprotective agent; physical tracer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
medroxyprogesterone acetate | | 20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; corticosteroid; steroid ester | adjuvant; androgen; antineoplastic agent; antioxidant; female contraceptive drug; inhibitor; progestin; synthetic oral contraceptive | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n,n'-diphenyl-4-phenylenediamine | | N-substituted diamine; secondary amino compound | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-di-tert-butylphenol | | alkylbenzene; phenols | antioxidant; bacterial metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lactobionic acid | | disaccharide | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl gallate | | gallate ester | anti-inflammatory agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-terpinene | | cyclohexadiene; monoterpene | antioxidant; human xenobiotic metabolite; plant metabolite; volatile oil component | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-isopropyl-n-phenyl-4-phenylenediamine | | N-substituted diamine | allergen; antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-tert-butyl-4-hydroxyanisole | | aromatic ether; phenols | antioxidant; human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl vanillin | | aromatic ether; benzaldehydes; phenols | antioxidant; flavouring agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
catechin | | catechin | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triethylenediamine | | bridged compound; diamine; saturated organic heterobicyclic parent; tertiary amino compound | antioxidant; catalyst; reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiazolidine-4-carboxylic acid | | alpha-amino acid zwitterion; non-proteinogenic alpha-amino acid; sulfur-containing amino acid; thiazolidinemonocarboxylic acid | antidote; antioxidant; hepatoprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methylcatechol | | methylcatechol | antioxidant; carcinogenic agent; hapten; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thymoquinone | | 1,4-benzoquinones | adjuvant; anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; cardioprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxyphenylethanol | | phenols | anti-arrhythmia drug; antioxidant; cardiovascular drug; fungal metabolite; geroprotector; plant metabolite; protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol | | terpineol; tertiary alcohol | anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; antiparasitic agent; apoptosis inducer; plant metabolite; volatile oil component | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diphenylamine | | aromatic amine; bridged diphenyl fungicide; secondary amino compound | antifungal agrochemical; antioxidant; carotogenesis inhibitor; EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor; ferroptosis inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acetylcysteine | | acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid | antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroferulic acid | | guaiacols; monocarboxylic acid; phenylpropanoid | antioxidant; human xenobiotic metabolite; mouse metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
d-alpha tocopherol | | alpha-tocopherol | algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diallyl trisulfide | | organic trisulfide | anti-inflammatory agent; antilipemic drug; antineoplastic agent; antioxidant; antiprotozoal drug; apoptosis inducer; estrogen receptor antagonist; insecticide; platelet aggregation inhibitor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl vanillate | | aromatic ether; benzoate ester; phenols | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zingerone | | methyl ketone; monomethoxybenzene; phenols | anti-inflammatory agent; antiemetic; antioxidant; flavouring agent; fragrance; plant metabolite; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butylated hydroxytoluene | | phenols | antioxidant; ferroptosis inhibitor; food additive; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,6-di-tert-butylphenol | | alkylbenzene; phenols | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
silybin | | aromatic ether; benzodioxine; flavonolignan; polyphenol; secondary alpha-hydroxy ketone | antineoplastic agent; antioxidant; hepatoprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | | chromanol; monocarboxylic acid; phenols | antioxidant; ferroptosis inhibitor; neuroprotective agent; radical scavenger; Wnt signalling inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oltipraz | | 1,2-dithiole; pyrazines | angiogenesis modulating agent; antimutagen; antineoplastic agent; antioxidant; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; neurotoxin; protective agent; schistosomicide drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
baicalin | | dihydroxyflavone; glucosiduronic acid; glycosyloxyflavone; monosaccharide derivative | antiatherosclerotic agent; antibacterial agent; anticoronaviral agent; antineoplastic agent; antioxidant; cardioprotective agent; EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; ferroptosis inhibitor; neuroprotective agent; non-steroidal anti-inflammatory drug; plant metabolite; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epigallocatechin gallate | | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylaspartic acid | | N-acetyl-L-amino acid; N-acyl-L-aspartic acid | antioxidant; human metabolite; mouse metabolite; nutraceutical; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salvin | | abietane diterpenoid; carbotricyclic compound; catechols; monocarboxylic acid | angiogenesis modulating agent; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; food preservative; HIV protease inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-hydroxydehydroepiandrosterone | | 17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; 7alpha-hydroxy steroid; androstanoid | anti-inflammatory agent; antioxidant; estrogen; human xenobiotic metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epicatechin | | catechin; polyphenol | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gallocatechol | | catechin; flavan-3,3',4',5,5',7-hexol | antioxidant; food component; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hesperetin | | 3'-hydroxyflavanones; 4'-methoxyflavanones; monomethoxyflavanone; trihydroxyflavanone | antineoplastic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vexibinol | | (2S)-flavan-4-one; 4'-hydroxyflavanones; tetrahydroxyflavanone | antimalarial; antimicrobial agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
brazilin | | catechols; organic heterotetracyclic compound; tertiary alcohol | anti-inflammatory agent; antibacterial agent; antineoplastic agent; antioxidant; apoptosis inducer; biological pigment; hepatoprotective agent; histological dye; NF-kappaB inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
madecassic acid | | monocarboxylic acid; pentacyclic triterpenoid; tetrol | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fangchinoline | | aromatic ether; bisbenzylisoquinoline alkaloid; macrocycle | anti-HIV-1 agent; anti-inflammatory agent; antineoplastic agent; antioxidant; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
corilagin | | ellagitannin; gallate ester | antihypertensive agent; antioxidant; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
maslinic acid | | dihydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl protocatechuate | | catechols; ethyl ester | antibacterial agent; antioxidant; apoptosis inducer; EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
decane-1,2-diol | | glycol; volatile organic compound | anti-inflammatory agent; antioxidant; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eriocitrin | | 3'-hydroxyflavanones; 4'-hydroxyflavanones; disaccharide derivative; flavanone glycoside; rutinoside; trihydroxyflavanone | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxymandelic acid | | 2-hydroxy monocarboxylic acid; catechols | antioxidant; drug metabolite; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sugiol | | abietane diterpenoid; carbotricyclic compound; cyclic terpene ketone; meroterpenoid; phenols | antineoplastic agent; antioxidant; antiviral agent; plant metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sesaminol | | benzodioxoles; furofuran; organic hydroxy compound | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
wr 1065 | | alkanethiol; diamine | antioxidant; drug metabolite; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cafestol | | diterpenoid; furans; organic heteropentacyclic compound; primary alcohol; tertiary alcohol | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kahweol | | diterpenoid; furans; organic heteropentacyclic compound; primary alcohol; tertiary alcohol | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
swertisin | | dihydroxyflavone; flavone C-glycoside; monomethoxyflavone; monosaccharide derivative; polyphenol | adenosine A1 receptor antagonist; anti-inflammatory agent; antioxidant; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rubiadin | | dihydroxyanthraquinone | antibacterial agent; antioxidant; hepatoprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ovothiol c | | aryl thiol; L-alpha-amino acid zwitterion; L-histidine derivative | antioxidant; marine metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ovothiol a | | aryl thiol; L-alpha-amino acid zwitterion; L-histidine derivative; non-proteinogenic L-alpha-amino acid | antioxidant; marine metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman | | benzopyran | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
schizandrin b | | aromatic ether; cyclic acetal; organic heterotetracyclic compound; oxacycle; tannin | anti-asthmatic agent; anti-inflammatory agent; antilipemic drug; antioxidant; apoptosis inhibitor; hepatoprotective agent; nephroprotective agent; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acrovestone | | acetophenones; aromatic ether; olefinic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4'-demethyldesoxypodophyllotoxin | | furonaphthodioxole; gamma-lactone; lignan; methoxybenzenes; phenols | antineoplastic agent; antioxidant; immunosuppressive agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
secoxyloganin | | beta-D-glucoside; dicarboxylic acid monoester; enoate ester; methyl ester; monosaccharide derivative; pyrans; secoiridoid glycoside | anti-allergic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pectolinarin | | dimethoxyflavone; disaccharide derivative; glycosyloxyflavone; monohydroxyflavanone; rutinoside | anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,5-dihydroxybenzyl alcohol | | aromatic primary alcohol; phenols | antineoplastic agent; antioxidant; apoptosis inhibitor; fungal metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sitosterol, (3beta)-isomer | | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C29-steroid; phytosterols; stigmastane sterol | anticholesteremic drug; antioxidant; mouse metabolite; plant metabolite; sterol methyltransferase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
erythritol | | butane-1,2,3,4-tetrol | antioxidant; human metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl 3,4-dihydroxybenzoate | | catechols; methyl ester | antioxidant; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sorbinil | | azaspiro compound; chromanes; imidazolidinone; organofluorine compound; oxaspiro compound | antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-dihydroxyphenylpropionic acid | | (dihydroxyphenyl)propanoic acid | antioxidant; human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-acetylneuraminic acid | | N-acetylneuraminic acids | antioxidant; bacterial metabolite; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carnosine | | amino acid zwitterion; dipeptide | anticonvulsant; antineoplastic agent; antioxidant; Daphnia magna metabolite; geroprotector; human metabolite; mouse metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
allose | | allopyranose; D-allose | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ginsenoside re | | 12beta-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; nephroprotective agent; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
notoginsenoside r1 | | 12beta-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid | antioxidant; apoptosis inducer; neuroprotective agent; phytoestrogen; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
stevioside | | beta-D-glucoside; bridged compound; diterpene glycoside; ent-kaurane diterpenoid; tetracyclic diterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; hypoglycemic agent; plant metabolite; sweetening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
genipin | | iridoid monoterpenoid | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cross-linking reagent; hepatotoxic agent; uncoupling protein inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
solasodine | | alkaloid antibiotic; azaspiro compound; hemiaminal ether; oxaspiro compound; sapogenin; steroid alkaloid | anticonvulsant; antifungal agent; antiinfective agent; antioxidant; antipyretic; antispermatogenic agent; apoptosis inducer; cardiotonic drug; central nervous system depressant; diuretic; immunomodulator; plant metabolite; teratogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tretinoin | | retinoic acid; vitamin A | anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
equilenin | | 17-oxo steroid; 3-hydroxy steroid | antioxidant; mammalian metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
resveratrol | | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oleic acid | | octadec-9-enoic acid | antioxidant; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; mouse metabolite; plant metabolite; solvent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ferulic acid | | ferulic acids | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cardioprotective agent; MALDI matrix material; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lycopene | | acyclic carotene | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pallidol | | carbopolycyclic compound; polyphenol; stilbenoid | antifungal agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
riboflavin | | flavin; vitamin B2 | anti-inflammatory agent; antioxidant; cofactor; Escherichia coli metabolite; food colouring; fundamental metabolite; human urinary metabolite; mouse metabolite; photosensitizing agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
piperlactam s | | alkaloid; aromatic ether; gamma-lactam; organic heterotetracyclic compound; phenols | anti-inflammatory agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-ionone | | ionone | antioxidant; fragrance | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propylthiouracil | | pyrimidinethione | antidote to paracetamol poisoning; antimetabolite; antioxidant; antithyroid drug; carcinogenic agent; EC 1.14.13.39 (nitric oxide synthase) inhibitor; hormone antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aurapten | | coumarins; monoterpenoid | antihypertensive agent; antineoplastic agent; antioxidant; apoptosis inducer; dopaminergic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; gamma-secretase modulator; gastrointestinal drug; hepatoprotective agent; matrix metalloproteinase inhibitor; neuroprotective agent; plant metabolite; PPARalpha agonist; vulnerary | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiourea | | one-carbon compound; thioureas; ureas | antioxidant; chromophore | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
u 0126 | | aryl sulfide; dinitrile; enamine; substituted aniline | antineoplastic agent; antioxidant; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; osteogenesis regulator; vasoconstrictor agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ferrostatin-1 | | ethyl ester; primary arylamine; substituted aniline | antifungal agent; antioxidant; ferroptosis inhibitor; neuroprotective agent; radiation protective agent; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sb 415286 | | C-nitro compound; maleimides; monochlorobenzenes; phenols; secondary amino compound; substituted aniline | antioxidant; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fraxetin | | aromatic ether; hydroxycoumarin | anti-inflammatory agent; antibacterial agent; antimicrobial agent; antioxidant; apoptosis inducer; apoptosis inhibitor; Arabidopsis thaliana metabolite; hepatoprotective agent; hypoglycemic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin | | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bilirubin | | biladienes; dicarboxylic acid | antioxidant; human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sinapine | | acylcholine | antioxidant; photosynthetic electron-transport chain inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercitrin | | alpha-L-rhamnoside; monosaccharide derivative; quercetin O-glycoside; tetrahydroxyflavone | antileishmanial agent; antioxidant; EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ubiquinone 9 | | ubiquinones | antioxidant; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta carotene | | carotenoid beta-end derivative; cyclic carotene | antioxidant; biological pigment; cofactor; ferroptosis inhibitor; human metabolite; mouse metabolite; plant metabolite; provitamin A | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
retinol palmitate | | all-trans-retinyl ester; retinyl palmitate | antioxidant; Escherichia coli metabolite; human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
luteolin-7-glucoside | | beta-D-glucoside; glycosyloxyflavone; monosaccharide derivative; trihydroxyflavone | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin 3-o-glucopyranoside | | beta-D-glucoside; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone | antineoplastic agent; antioxidant; antipruritic drug; bone density conservation agent; geroprotector; histamine antagonist; osteogenesis regulator; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zeaxanthin | | carotenol | antioxidant; bacterial metabolite; cofactor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
butein | | chalcones; polyphenol | antineoplastic agent; antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; geroprotector; hypoglycemic agent; plant metabolite; radiosensitizing agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
astaxanthine | | carotenol; carotenone | animal metabolite; anticoagulant; antioxidant; food colouring; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gardenia yellow | | diester; disaccharide derivative; diterpenoid | antioxidant; food colouring; histological dye; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cryptoxanthins | | carotenol | antioxidant; biomarker; plant metabolite; provitamin A | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
esculetin | | hydroxycoumarin | antioxidant; plant metabolite; ultraviolet filter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oleuropein | | beta-D-glucoside; catechols; diester; methyl ester; pyrans; secoiridoid glycoside | anti-inflammatory agent; antihypertensive agent; antineoplastic agent; antioxidant; apoptosis inducer; NF-kappaB inhibitor; nutraceutical; plant metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
baicalein | | trihydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 4.1.1.17 (ornithine decarboxylase) inhibitor; ferroptosis inhibitor; geroprotector; hormone antagonist; plant metabolite; prostaglandin antagonist; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chrysin | | 7-hydroxyflavonol; dihydroxyflavone | anti-inflammatory agent; antineoplastic agent; antioxidant; EC 2.7.11.18 (myosin-light-chain kinase) inhibitor; hepatoprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diosmetin | | 3'-hydroxyflavonoid; monomethoxyflavone; trihydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; bone density conservation agent; cardioprotective agent; plant metabolite; tropomyosin-related kinase B receptor agonist; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diosmin | | dihydroxyflavanone; disaccharide derivative; glycosyloxyflavone; monomethoxyflavone; rutinoside | anti-inflammatory agent; antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hispidulin | | monomethoxyflavone; trihydroxyflavone | anti-inflammatory agent; anticonvulsant; antineoplastic agent; antioxidant; apoptosis inducer; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mangiferin | | C-glycosyl compound; xanthones | anti-inflammatory agent; antioxidant; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mangostin | | aromatic ether; phenols; xanthones | antimicrobial agent; antineoplastic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,2,8-trihydroxy-6-methoxyxanthone | | aromatic ether; polyphenol; xanthones | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
myricetin | | 7-hydroxyflavonol; hexahydroxyflavone | antineoplastic agent; antioxidant; cyclooxygenase 1 inhibitor; food component; geroprotector; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetagetin | | flavonols; hexahydroxyflavone | antioxidant; antiviral agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
coumestrol | | coumestans; delta-lactone; polyphenol | anti-inflammatory agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pterostilbene | | diether; methoxybenzenes; stilbenol | anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; hypoglycemic agent; neuroprotective agent; neurotransmitter; plant metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ellagic acid | | catechols; cyclic ketone; lactone; organic heterotetracyclic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor; EC 2.4.1.1 (glycogen phosphorylase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor; EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor; EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; food additive; fungal metabolite; geroprotector; plant metabolite; skin lightening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
coenzyme q10 | | ubiquinones | antioxidant; ferroptosis inhibitor; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin-3-o-sophoroside | | sophoroside; tetrahydroxyflavone | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gamma-tocotrienol | | tocotrienol; vitamin E | antineoplastic agent; antioxidant; apoptosis inducer; hepatoprotective agent; plant metabolite; radiation protective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
menatetrenone | | menaquinone | anti-inflammatory agent; antioxidant; bone density conservation agent; human metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nk 104 | | calcium salt; statin (synthetic) | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pitavastatin | | cyclopropanes; dihydroxy monocarboxylic acid; monofluorobenzenes; quinolines; statin (synthetic) | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenretinide | | monocarboxylic acid amide; retinoid | antineoplastic agent; antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rosmarinic acid | | carboxylic ester; monocarboxylic acid; phenylpropanoid; polyphenol | antioxidant; EC 1.1.1.21 (aldehyde reductase) inhibitor; non-steroidal anti-inflammatory drug; peripheral nervous system drug; plant metabolite; serine proteinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cannabigerol | | phytocannabinoid; resorcinols | anti-inflammatory agent; antibacterial agent; antioxidant; appetite enhancer; cannabinoid receptor agonist; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quadrangularin a | | indanes; polyphenol; stilbenoid | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isosalipurposide | | beta-D-glucoside; chalcones; monosaccharide derivative; resorcinols | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
icariin | | flavonols; glycosyloxyflavone | antioxidant; bone density conservation agent; EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; phytoestrogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methylesculetin | | hydroxycoumarin | anti-inflammatory agent; antioxidant; hyaluronan synthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
spiraeoside | | beta-D-glucoside; flavonols; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone | antineoplastic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(E)-2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside | | beta-D-glucoside; resorcinols; stilbenoid | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cardioprotective agent; cyclooxygenase 2 inhibitor; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ag-490 | | catechols; enamide; monocarboxylic acid amide; nitrile; secondary carboxamide | anti-inflammatory agent; antioxidant; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector; STAT3 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ergothioneine | | 1,3-dihydroimidazole-2-thiones; amino-acid betaine; L-histidine derivative; sulfur-containing amino acid | antioxidant; chelator; fungal metabolite; plant metabolite; xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
molsidomine | | ethyl ester; morpholines; oxadiazole; zwitterion | antioxidant; apoptosis inhibitor; cardioprotective agent; nitric oxide donor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monomethyl fumarate | | dicarboxylic acid monoester; enoate ester; methyl ester | antioxidant; drug metabolite; immunomodulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,4'-dihydroxy-7,3'-dimethoxyflavone | | dihydroxyflavone; dimethoxyflavone | anti-allergic agent; anti-inflammatory agent; antibacterial agent; antioxidant; melanin synthesis inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quercetin 3-sambubioside | | disaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
germacrone | | germacrane sesquiterpenoid; olefinic compound | androgen antagonist; anti-inflammatory agent; antifeedant; antifungal agent; antimicrobial agent; antineoplastic agent; antioxidant; antitussive; antiviral agent; apoptosis inducer; autophagy inducer; hepatoprotective agent; insecticide; neuroprotective agent; plant metabolite; volatile oil component | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
meso-zeaxanthin | | carotenol | anti-inflammatory agent; antioxidant; human xenobiotic metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salvianolic acid B | | 1-benzofurans; catechols; dicarboxylic acid; enoate ester; polyphenol | anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; apoptosis inducer; autophagy inhibitor; cardioprotective agent; hepatoprotective agent; hypoglycemic agent; neuroprotective agent; osteogenesis regulator; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trilobatin | | aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative | anti-inflammatory agent; antioxidant; plant metabolite; sweetening agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
capsiate | | carboxylic ester; monomethoxybenzene; phenols | angiogenesis inhibitor; anti-allergic agent; anti-inflammatory agent; antioxidant; capsaicin receptor agonist; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tln 4601 | | dibenzodiazepine; farnesane sesquiterpenoid; olefinic compound; secondary amine; triol | antineoplastic agent; antioxidant; cathepsin L (EC 3.4.22.15) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arachidonoylserotonin | | N-acylserotonin; phenols | anti-inflammatory agent; anticonvulsant; antioxidant; capsaicin receptor antagonist; EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor; human metabolite; signalling molecule | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nigerloxin | | aromatic ether; benzamides; benzoic acids; phenols; styrenes | antioxidant; Aspergillus metabolite; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aspalathin | | C-glycosyl compound; catechols; dihydrochalcones; polyketide; polyphenol | antioxidant; EC 1.17.3.2 (xanthine oxidase) inhibitor; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glyceryl ferulate | | 1-monoglyceride; aromatic ether; enoate ester; phenols | antioxidant; plant metabolite; ultraviolet filter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(+)-dehydrodiconiferyl alcohol | | dehydrodiconiferyl alcohol | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ginsenoside rb3 | | 12beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid | antidepressant; antioxidant; cardioprotective agent; neuroprotective agent; NMDA receptor antagonist; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
astragaloside IV | | pentacyclic triterpenoid; triterpenoid saponin | anti-inflammatory agent; antioxidant; EC 4.2.1.1 (carbonic anhydrase) inhibitor; neuroprotective agent; plant metabolite; pro-angiogenic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-O-feruloyl-beta-D-glucose | | aromatic ether; beta-D-glucoside; cinnamate ester; phenols | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyranonigrin a | | cyclic ketone; enol; gamma-lactam; pyranopyrrole; secondary alcohol | antioxidant; Aspergillus metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
madecassoside | | carboxylic ester; pentacyclic triterpenoid; trisaccharide derivative; triterpenoid saponin | anti-inflammatory agent; antioxidant; antirheumatic drug; plant metabolite; vulnerary | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bacillithiol | | glycoside; monosaccharide derivative; thiol | antioxidant; bacterial metabolite; cofactor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kurarinol | | 4'-hydroxyflavanones; monomethoxyflavanone; trihydroxyflavanone | anti-inflammatory agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(20R)-ginsenoside Rg3 | | ginsenoside; glycoside; tetracyclic triterpenoid | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hispidin | | 2-pyranones; catechols | antioxidant; EC 2.7.11.13 (protein kinase C) inhibitor; fungal metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oleuropein aglycone | | catechols; diester; lactol; methyl ester; pyrans; secoiridoid | anti-inflammatory agent; antioxidant; mTOR inhibitor; neuroprotective agent; plant metabolite; TRPA1 channel agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-hydroxy-2,4,5-triaminopyrimidine | | aminopyrimidine; hydroxypyrimidine | antioxidant; chromophore | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
liproxstatin-1 | | azaspiro compound; monochlorobenzenes; organic heterotricyclic compound; secondary amino compound | antioxidant; cardioprotective agent; ferroptosis inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |